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ABSTRACT

Kerian, Kevin S. Ph.D., Purdue University, May 2015. Molecular Diagnosis of Cancer
using Ambient Ionization Mass Spectrometry. Major Professor: R. Graham Cooks.

My dissertation focuses on advancing the development and application of ambient
ionization mass spectrometry methodology and technology to the biomedical field. The
primary ambient ionization method used in my studies is desorption electrospray ionization
mass spectrometry (DESI-MS) imaging, which has been previously used to analyze and
differentiate disease state (i.e. tumor and normal) and in some cases tumor subtype of
human liver, kidney, bladder, testicular, prostate, and brain cancers. DESI-MS imaging is
an ideal method for disease diagnosis, because it can be used to directly correlate disease
state with histopathology to develop and validate MS libraries built using the molecular
profiles that relate to tissue disease states. The goal of this research is to use ambient
ionization mass spectrometry for intraoperative surgical-guidance to more accurately
diagnose tissue and reduce surgical times.
Technological developments during the course of research revolved around touch
spray ambient ionization mass spectrometry (TS-MS). This method uses a small probe (e.g.
teasing needle) to pick up a minuscule amount of material from a sample, transfer the probe
to the front of a mass spectrometer, and, with the addition of high voltage and solvent,
induce ESI-like mechanisms for ionization. An evaluation of TS for its use as a

xv
potential in vivo surgical tool for disease screening was performed by concurrently
studying prostate cancer tissue obtained from surgery with DESI-MS imaging. DESI
imaging was used to first establish the relationship between MS molecular profiles and
pathology which were then targeted using TS. Further, TS was also evaluated as a nontargeted technique by analyzing prostate specimens with unknown disease states and
comparing the unknown data to the previously built MS targeted library.
Methodological developments include DESI-MS studies for preliminary diagnosis
of disease state and tumor subtyping using fine needle aspirations (FNA) of canine
lymphoma specimens. Lipid profiles obtained from FNA samples were tested against a MS
library built from a matched set of surgical tissue sections with disease states confirmed by
histopathology. DESI-MS imaging was also used to expand upon previously investigated
human kidney cancer. Previous investigations included two subtypes and low sample
numbers (~10 paired normal and tumor samples per subtype), this more recent study
includes the top three most commonly diagnosed subtypes (clear cell, papillary, and
chromophobe) and higher sample numbers (~20 paired normal and tumor samples per
subtype).
In summary, many methodological and technological advances were made during
the course of my dissertation studies. These advances include the development of a novel
ambient ionization method, an extension of current applications to include FNA samples
for early diagnosis, and an expansion of previous work to build more complex and
comprehensive MS libraries. Advances such as these continue to propel ambient ionization
mass spectrometry deeper into the biomedical field and gives hope to the use of chemical
profiling using these methods for biomedical applications in the near future.

1

CHAPTER 1. INTRODUCTION

1.1

Mass Spectrometry Imaging

Molecular imaging is a continuously growing field in mass spectrometry (MS) with
interest from persons in many areas of scientific research. The combination of detailed
chemical information from MS and the spatial distribution of those chemicals in the form
of a digital image provides information which was previously under- or uninvestigated.
Although MS imaging has a long history dating back to the early 1960’s, major interest did
not occur until the 1990’s.1,2 This interest was primarily due to two MS ionization
techniques, secondary ion mass spectrometry (SIMS)3 and matrix assisted laser desorption
ionization (MALDI).4 Each ionization technique is responsible for its share of MS imaging
success, SIMS initially due to its biological applications with high spatial resolution and
MALDI initially due to its powerful combination with a time of flight mass spectrometer.
These developments and others pushed MS imaging into numerous fields of promising
research such as, forensic sciences, material sciences, and biomedical sciences.5-7 One
promising application of MS imaging to date has been disease diagnosis where multiple
MS imaging methods have shown correlation of molecular information and disease state.8
The molecular information may serve as a complementary technique to standard
pathological evaluation of disease state.
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SIMS is carried out under vacuum using a primary ion beam of kiloelectron volt
(keV) energy to bombard and eject secondary ions from a surface that are analyzed by a
MS. Traditionally, there are primarily two operational modes of SIMS, static SIMS and
dynamic SIMS, which are categorized by the current density of the primary ion beam.
Dynamic SIMS utilizes a high current density ion beam (>1013 ions/cm2) and static SIMS
a low current density ion beam (<1013 ions/cm2). Each mode produces different SIMS
results, dynamic SIMS conditions result in a more destructive environment where the
primary ion beam will cause surface sputtering allowing a depth profile (nanometers to
micrometers) to a sample by successively eroding the sample surface, but due to the high
current conditions will primarily generate elemental and small cluster secondary ions for
analysis. Alternatively, the low current primary ion beam of static SIMS allows structurally
intact organic secondary ions to be generated and for minimal damage to a samples surface,
making this mode minimally destructive.9,10 Technological and methodological advances
such as time-of-flight (ToF) mass analyzers and cluster ion sources continue to increase
SIMS sensitivity and usefulness for complex samples and low concentration analytes.
Development of different cluster ion and polyatomic ion sources have paved the way for
biological imaging with SIMS by reducing chemical damage to samples, reducing
secondary ion fragmentation, and also increasing secondary ion yields. Possibly the most
important and distinguishing feature of SIMS is the high spatial resolution compared to
that of other imaging methods.9,11 SIMS is regularly reported with sub-micrometer spatial
resolution and has been reported to produce distributions of biochemical compounds at
spatial resolutions of 100 nm and below.12
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Similar to SIMS, MALDI is also normally performed under vacuum, however
MALDI utilizes UV/IR laser pulses instead of a primary ion beam to interrogate the sample
surface. MALDI also uses an organic matrix which is applied to the sample prior to analysis
to help with desorption and ionization. The mechanism of ionization by this method is still
greatly debated. Although the exact mechanism is not known, it is known that the type of
organic matrix used and the application of said matrix to a sample can strongly affect the
quality of MALDI images.10 One major effect MALDI matrices can have is the ability to
resolve different chemical classes, thus a major effort has been put forth to develop
matrices for specific chemical classes including larger biomolecules (e.g. proteins and
peptides) and smaller biomolecules (e.g. lipids and metabolites), as well as illicit and
therapeutic drugs.13-15 Although spatial resolution of MALDI imaging is inherently limited
by the laser’s focal diameter, displacement of analytes during matrix deposition is the other
main limiting factor.16 However, developments in matrix deposition as well as laser optics
make spatial resolution of single eukaryotic cells achievable by MALDI imaging. In
contrast to SIMS, MALDI is considered a soft ionization technique (i.e. little to no
fragmentation) which primarily produces singly protonated ions or alkali metal adducted
ions. The most successful application of MALDI imaging has been its use in peptide and
protein studies for cancer diagnosis. One of the first such works reported on the molecular
changes of peptides and proteins in different regions of a human glioblastoma tumor from
nude mouse xenograft tissue sections.13 MALDI imaging has been used to study cancers
from animal subjects to human subjects and has been used to investigate many complex
biological matrices including different tissue types, whole blood, blood serum, blood
plasma, saliva, and urine.17 Although cancer studies by MALDI imaging are some of the
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more well-known studies, MALDI has also been used to study the proteome of other
diseases such as neurodegenerative diseases, Alzheimer’s and Parkinson’s.18,19 Aside from
studies related to disease, MALDI imaging has also been used to examine different
therapeutic drug processes, for example to map distribution changes of a drug and its
metabolites in tissue when the drug was administered at differing dosages.20
The development of ambient ionization techniques caused an expansion in MS
imaging applications. Specifically, a surge in clinical imaging applications was caused by
the development of ambient ionization MS where one main goal is to provide real-time
information on disease state during surgical procedures.21,22 The possibility of this
application and many like it is due to the nature of ambient ionization methodology where
unlike conventional SIMS and MALDI, ambient ionization techniques do not require
sample introduction into a vacuum or sample pre-treatment such as the addition of organic
matrices. Analysis by ambient ionization techniques is performed with little to no sample
preparation and in the ambient environment allowing for molecular information to
collected within seconds.23 The use of ambient ionization MS imaging for applications of
diagnosis has been extensively studied and successfully demonstrated by desorption
electrospray ionization (DESI), the most well-known and commonly used ambient
ionization technique.

1.2

Ambient Ionization Mass Spectrometry

The introduction of ambient ionization techniques began in 2004 with the
development of desorption electrospray ionization or DESI.24 Since its development,
ambient ionization has expanded to include many different techniques which can be
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subcategorized based on each technique’s method of desorption and ionization. The three
main categories are: Liquid extraction methods, spallation methods, and thermal desorption
methods.25
Liquid extraction methods are by far the largest group of ambient ionization
techniques and can be further broken down into the groups of spray desorption, substrate
spray, and liquid microjunction. Each of the liquid extraction methods use either liquidliquid extraction or liquid-solid extraction to desorb analytes from their matrix and the
electrospray ionization (ESI) mechanism for ionization, however they differ based on the
method by which the extracted analytes are presented to the ionization event.26 Spray
desorption methods, the group in which DESI is categorized, use a charged solvent spray
to first desorb analytes by directing the primary spray towards the sample, creating a thin
film of the spray solvent on the sample, and continual collisions of the primary spray
droplets emit charged secondary droplets from the sample surface containing small
amounts of the extracted analyte. The secondary droplets undergo evaporation and
coulombic fission generating ions as the secondary and subsequent progeny droplets are
propelled towards the inlet of the mass spectrometer.27,28 In the substrate spray methods
desorption and ionization occur directly from the same sample substrate device. The
substrate typically has a sharp tip and can be used to extra a small amount of material from
the sample and then by addition of solvent and high voltage, analytes can be desorbed from
the extracted material and ionized.29,30 The last of the liquid extraction groups is the liquid
microjunction group of method. These methods use a continuous liquid interface in the
form of a solvent bridge from a primary capillary or pipet to the sample. Analytes are
desorbed into the microjunction while being prepared to be ionized for analysis.31,32
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Spallation of material from a sample occurs by delivering high energy into a small
area to create shockwaves which cause desorption or ablation of said material. The majority
of spallation methods use a high energy laser, however other methods have been reported.33
Typically another technique is then coupled with the spallation process to capture the
ejected material and ionize the analytes, ESI being the most commonly paired method.34,35
The last category for ambient ionization techniques described is thermal desorption.
These are primarily plasma-based methods which use an electrical discharge to desorb and
ionize analytes. Not all plasma-based methods employ thermal desorption, however it has
been noted in many cases that the range of detectable species increases when the discharge
gas is externally heated. Plasmas for these methods have been created by a number of
means including direct-current, radio frequency glows, coronas, dielectric-barrier
discharges, microhollow cathode discharges, and microwaves plasmas.36-39 Although many
small organic species can be detected from surfaces using plasma techniques, they are
categorized into thermal desorption methods, because the number of species detectable
greatly increases with the use of an externally heated discharge gas, which many employ.
This is thought to be due to the increase of molecules into the vapor phase by thermal
desorption processes. Ionization for these techniques can occur through a number of
pathways, the five most dominate pathways observed are proton transfer, charge transfer,
electron capture, ion attachment, and proton/hydride abstraction.25

1.3

DESI-MS Imaging

DESI, as mentioned above, falls into the ambient ionization category of liquid
extraction, and more specifically the subcategory of spray desorption. DESI uses two silica
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capillaries, an inner and an outer, where charged solvent is flowed through the inner
capillary and a nebulizing gas (i.e. nitrogen) is flowed between the inner and the outer
capillary. The nebulizing gas helps propel the solvent from the inner capillary to create a
primary spray of charged droplets from the DESI source.40 The primary spray is directed
towards a sample surface where the initial collisions of droplets create a thin film of solvent
on the surface where by liquid-solid extraction analytes are desorbed from the sample and
into the thin film. The continual bombardment of the thin film with the charged primary
droplets causes the formation of charged secondary droplets containing the now desorbed
analytes.41 The secondary droplets subsequently undergo ESI mechanisms and ionize the
analytes which are introduced to the MS.42
DESI has primarily been used as an MS imaging method through the use of a 2dimensional moving stage. The DESI source is conventionally held in a stationary position
with an incident angle of ~35-60o spraying directly at an unmodified sample while the
moving stage moves the sample at a continuous speed in the x direction. The MS scan time
and moving stage speed are set to produce a spatial resolution in the x direction of ~150250 µm. Each line in the x dimension is separately recorded and spaced in the y dimension
typically by step sizes identical to the calculated step size to those in the x dimension
(scanning in x dimension is continuous, but can be calculated using the MS scan time and
moving stage speed).23 This process of imaging has been used for applications ranging
from forensic studies such as the detection of counterfeit currency or illicit drug detection
from latent fingerprints to studies of natural products and their distributions in bacteria
grown on agar plates.7,43,44 However, some of the most valuable research with DESI-MS
imaging are related to the diagnosis of disease, and specifically the diagnosis of cancers.
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The standard method for diagnosis of cancer is histopathological evaluation of tissue
sections by a histopathologist. The method of diagnosis through histopathology is based
on morphological and cytological features of tissue sections, such as morphological growth
pattern, nuclear size and shape, and mitotic index.45,46 These features can be identified
through the use of histological stains such as hematoxylin and eosin (H&E), but other
immunohistochemical stains can be used for the identification of specific cancers by
staining proteins specific to those cancers such as neprilysin for clear cell carcinomas or
stem cell growth factor receptor (SCFR) for gastrointestinal stromal tumors.47,48 Although
these methods are the gold standard for diagnosis of cancer, ambiguity in histopathology
can still occur quite frequently. New methodologies such as DESI imaging can be used to
support pathological evaluations of suspected diseased tissue using spatially obtained
molecular profiles. Conventional DESI imaging studies have been performed in negative
ion mode, where the detection of ions are primarily in the form of [M-H]-. When analyzing
tissue, M is typically a lipid species which can be generally identified when detected in the
following m/z ranges 180-350, 350-650, and 650-1000 as a fatty acid, fatty acid dimer, or
glycerophospholipid species respectively. Depending on the mass analyzer used, the exact
identification of each ion or lipid detected can be more easily determined. A molecular
profile is the mass distribution of the detected species and their relative abundance to one
another in a single mass spectrum. The spatial distribution of molecular profiles can be
used to classify tissue with certain features (e.g. tissue types), as seen in Figure 1-1 where
the molecular profile produced from a coronal mouse brain section changes when
analyzing white brain matter versus grey brain matter. DESI imaging has been successfully
used for differentiation of cancer and normal disease states in human liver49, bladder50,
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kidney51, prostate52, testicular53, and brain54,55 tissues. Further evaluation of the molecular
profiles have been used in particular cases to also distinguish cancer subtypes from one
another, as is the case with human brain and kidney cancers.51,56 The rich information
obtained through methods such as DESI imaging has yet to be applied in clinical or surgical
settings, however the value of this information can be seen through the support by
clinicians, surgeons, and pathologists who participate in molecular diagnosis research with
these methods.

1.4

Research Objectives

The research focus of this dissertation is on advancing the development and
application of ambient ionization mass spectrometry methodology and technology to the
biomedical field. This is accomplished by using DESI-MS as the core ambient ionization
technique for the development and validation of MS libraries containing molecular profiles
related to tissue disease states. The goal of this research is to use ambient ionization mass
spectrometry for more accurate diagnosis during intraoperative surgical-guidance and to
reduce surgical times, which in turn can reduce the risk of infection and complications
during surgery. Developments during the course of research led to the invention of a new
ambient ionization technique which was incorporated to the research focus and at times
used concurrently with DESI-MS for the diagnosis of cancer.
Chapter 2 describes the research involved in the development of the novel ambient
ionization technique, touch spray ambient ionization mass spectrometry. Touch spray (TS)
uses a small probe (e.g. teasing needle) to pick up negligible amounts material from a
sample and to transfer the material to the front of a mass spectrometer. The addition of
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organic solvent extracts analytes from the adsorbed material and the addition of high
voltage induces ESI-like processes to generate ions via coulombic fission and evaporation
of the emitted charged droplets. The development of this method as described is for the use
of tissue analysis for disease diagnosis applications, however this method was also
explored for applications related to microorganism identification, therapeutic drug
quantitation, and related small molecule detection.
An evaluation of TS for its use as a potential in vivo surgical tool for disease
screening is described in Chapter 3. This evaluation was performed by concurrently
studying prostate cancer tissue obtained from surgery with DESI-MS imaging and TS-MS.
DESI imaging has previously been used to study the molecular differences between tissue
disease states with great success, however TS capabilities for disease diagnosis had not
been established. Discussion about fundamental differences and similarities between nontargeted detection using DESI imaging methodology and targeted single point detection
using TS methodology is also represented in Chapter 3. These features allowed for DESI
imaging to first establish the relationship between MS molecular profiles and pathological
findings which were then targeted using TS. This chapter also includes an assessment of
TS when used as a non-targeted technique on unknown disease state specimen,
representing a situation more closely related to its proposed surgical use.
Many animal models closely mimic disease characteristics of human cancers such
as disease progression and disease subtype occurrence as is the case with canine nonHodgkin’s lymphoma (NHL). Comparative models can give invaluable information for the
understanding of specific diseases outside of the studied species, but are also important in
their own regards. Chapter 4 describes the use of DESI imaging for the analysis of canine
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NHL and normal tissue with the goal of determining molecular information suitable for
differentiation of healthy and diseased tissue. Further, molecular patterns for NHL subtypes
B-cell and T-cell were investigated since disease treatment has been known to differ based
on tumor subtype in certain cases. Preliminary diagnosis for NHL is typically done through
an invasive lymph node dissection procedure, however fine needle aspiration (FNA)
procedures have been used as a less invasive alternative method. FNA procedures are also
less expensive and more rapid than traditional procedures, but also less reliable since
diagnosis relies only on cytology (i.e. loss of cellular information in respect to surrounding
tissue). The last objective described in Chapter 4 is the use of DESI-MS to obtain molecular
information from FNA samples for comparison to lymph node dissection samples.
Evaluation of renal cell carcinoma (RCC) specimen by DESI-MS imaging has
previously been reported.51 Briefly, 11 paired human papillary RCC specimen and nine
paired clear cell RCC specimen were evaluated by DESI imaging and processed using a
supervised multivariate statistical technique. The classification of tumor and normal was
performed separately for each subtype with averaged classification rates for papillary and
clear cell RCC of 14.3% and 7.8% respectively. The classification of subtype and normal
was then performed with an overall averaged classification result of 76.3%. Chapter 5
discusses an extension of this initial work and includes a higher number of specimen per
disease state and another subtype, chromophobe RCC. Together, clear cell, papillary, and
chromophobe RCC represent ~99% of all diagnosed RCC cases.57 The objective described
in this Chapter is to build a comprehensive MS library for all major RCC subtypes.
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Figure 1-1 Lipid patterns and specific lipid distributions which correlate to different mouse
brain tissue types. A) Distribution of m/z 834 in a coronal mouse brain section with high
relative intensities highly correlating to gray matter. B) Representative spectrum from gray
matter in the mouse brain tissue section. C) Distribution of m/z 888 in a coronal mouse
brain section with high relative intensities highly correlating to white matter. D)
Representative spectrum from white matter in the mouse brain tissue section.
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CHAPTER 2. TOUCH SPRAY IONIZATION MASS SPECTROMETRY

2.1

Introduction

Since the development of DESI-MS in 20041 more than forty ambient ionization
methods have been described.2-4 As discussed in Chapter 1, these ionization methods can
be broken into 3 categories based on each methods process of desorption and ionization:
Liquid extraction, laser ablation, or thermal desorption.5 One of the main characteristics
consistent among all categories of ambient ionization is the speed of analysis which
requires a few seconds for the entire process of sampling, ionization, and recording of mass
spectra. The cause of this feature is the result of eliminating or greatly reducing sample
pre-treatment, including avoiding separation techniques prior to mass spectrometry.
Despite avoiding pre-treatment, ambient ionization displays wide applicability combined
with high sensitivity and high molecular specificity characteristic of mass spectrometry.3,6
Liquid extraction methods, as described in Chapter 1, are by far the largest group of
ambient ionization methods and include DESI1, nanospray desorption electrospray
ionization (nanoDESI)7, liquid microjunction suface-sampling probe (LMJ-SSP)8, probe
electrospray ionization (PESI)9, and others. Each case can be further broken down into
their respective subcategory of either spray desorption, substrate spray, or liquid
microjunction based on their process of desorption. Although the methods listed
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above may differ by desorption processes, each case uses solvent and high voltage to
generate the strong electric field needed to produce charged secondary droplets carrying
dissolved analyte to the mass spectrometer. The charged droplets undergo coulombic
fission when sufficient surface charge is accumulated as a result of solvent evaporation,
eventually yielding analyte ions by mechanisms that parallel those in electrospray
ionization.
Substrate spray methods differ from the other liquid extraction methods, because
desorption and ionization occur from the same sample substrate.5 Included in this family
of methods is paper spray (PS)10, PESI11, and leaf spray (LS).12 Substrate spray methods
generate ions from sharp tips, naturally present or created, and require a minute amount of
sample. Touch spray (TS) ionization also falls into this family of substrate spray methods,
using a probe (e.g. teasing needle) to adsorb material from a sample and the use of solvent
and an electrical potential to desorb analytes and transfer them in ionic form into a mass
spectrometer by methods discussed above. TS allows for in vivo sampling of material and
ex vivo analysis once solvent (as needed) and a potential are applied. This method is closely
related to the metallic probe substrate techniques such as PESI and organic substrate
techniques such as PS, and characterized by the ability to sample and absorb materials such
as solid powders, trace amounts of solids on surfaces, solutions, and heterogeneous
matrices (e.g. tissue) onto a probe. Absorbed material can be transported from the point of
origin to the MS in two stages, first by physical transfer of a small sample and then by
transfer of dissolved analytes in the sprayed droplets. TS, as with other spray-based
ambient ionization methods, allows nearly simultaneous chemical derivatization and
ionization, generating derivatives that can increase signal and enhance qualitative
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identification. This chapter describes the methodology of TS and explores applications,
with emphasis on in situ analysis via illustrative examples.

2.2

Experimental

2.2.1 Biological Tissue Samples

2.2.1.1 Mouse Brain Tissue
Mouse brain tissue was acquired from JAX® Mice and Services (Bar Harbor,
Maine, USA). A mouse brains was sectioned at 15 μm and thaw mounted onto glass
microscope slides. The slides were stored in closed containers at −20 °C; prior to analysis
they were allowed to come to room temperature and dried in an electronic desiccator for
approximately 20 minutes.

2.2.1.2 Human Prostate Tissue
Radical

prostatectomy

specimens

were

obtained

from

consented

patients via Indiana School of Medicine (Indianapolis, IN). Biopsies were obtained using
a disposable biopsy gun in accordance with an IRB approved protocol. Biopsies were
frozen, cryosectioned at 15 μm and thaw mounted to glass microscope slides. Sections
were stored at −80 °C prior to analysis. Histopathology was performed upon H&E staining
prostate biopsies by an expert pathology.
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2.2.2 Bacteria Culturing
E. coli strains were supplied by bioMérieux, Inc. (Hazelwood, MO) and cultured
from frozen samples stored at −80 °C in TSAB. Bacteria were cultured on TSA with 5%
sheep blood (Remel, Lenexa, KS) and incubated in a VWR incubator (Chicago, IL) at 37
± 1 °C for approximately 24 h, sub-cultured for an additional 24 h, and then used in TSMS experiments.

2.2.3 Materials

2.2.3.1 Touch Spray Probe
The TS probe used is a commercially available teasing needle purchased from
Fisher Scientific (Pittsburgh, PA, USA) while multiple variants also were tested.

2.2.3.2 Chemical and Non-Biological Materials
The spray solvent used for MS acquisition was methanol, purchased from
Mallinckrodt Baker Inc. (Phillipsburg, NJ), and applied manually via an adjustable pipette
(Eppendorf

Research-2.5

μL).

Additional

spray

additives

including

3-[(3-

cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) was purchased from
Sigma-Aldrich (St. Louis, MO). Therapeutic drugs were acquired from Cerilliant (Round
Rock, Texas, USA). Drugs were stored at −20 °C until diluted in bovine blood to
appropriate concentrations. Illicit drugs were acquired from Cerilliant (Round Rock,
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Texas, USA). Drugs were stored at −20 °C until diluted to appropriate concentrations. Nonorganic orange was purchased from national grocer for agrochemical MS experiments.

2.2.4 Instrumentation
A LTQ linear ion trap (Thermo Fisher Scientific) was used in experiments unless
otherwise specified and carried out with the auto gain control (AGC) activated.

2.3

Results and Discussion

2.3.1 Touch Spray Ionization
Touch spray ionization is aimed at in vivo sampling and ex vivo analysis of complex
samples. One specific application envisioned for touch spray is its use as an intraoperative
tool for rapid diagnosis of tissue disease states to help guide surgical procedures. Analytes
are transferred from a particular location in the sample to a roughed probe by adsorption.
Subsequently, solvent and high voltage are used to induce spray ionization processes which
ionize the analyte and transfer it to the mass spectrometer for analysis. The TS method
incorporates a user guided method of collecting a MS sample: sampling is remote to the
mass spectrometer and after material transfer onto a probe, MS is performed directly from
the sampling device. It is not necessary to use a specific probe material or that it have a
particular physical form: the transfer of a minute amount of material for MS analysis can
be achieved by touching, scratching, dipping, swiping, or otherwise attaching sample
material. The probe is then aligned with the mass spectrometer, high voltage is applied,
solvent is added, and mass spectra are recorded. In these experiments the touch spray probe
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was aligned with the atmospheric inlet (2-5 mm away) and an appropriate voltage (4.5 kV)
was applied to generate a stable electrospray signal without a corona discharge. Solvent
was either applied manually via pipette (1 μL, which provided mass spectral signals lasting
only a few seconds) or continuously via a syringe pump (yielding continuous signal until
analyte exhaustion, typically >1 min). The values listed above gave the most reproducible
TS results, however stable electrospray conditions were tested and achieved with probe to
inlet distances of 0.5-20 mm, applied voltages of 3-5 kV, and manual solvent additions of
0.1-2 μL.
One suitable probe is a teasing needle (Figure 2-1); these are metallic, possess a
sharp tip, and are roughened. The metallic and roughened features appear to be beneficial
when sampling and transferring material, such as biological tissue. The crevasses in the
roughened surface hold material during sample transfer and analysis, facilitating analyte
extraction. In addition, in the case of teasing needles, the angled feature was found to
increase reliability, as it accommodated solvent application and was observed to promote
solvent flow. Complete wetting of the probe's surface improved extraction of analytes and
emission of solvent microdroplets, a feature which was not observed in all probes
evaluated.
Touch spray is user-guided, placing limits on the rate and reproducibility of
sampling. It is therefore semi-quantitative with performance dependent on user experience.
However, it allows ready assessment of the presence or absence of analytes in situ or in
vivo, information that is critical for applications in fields such as forensics and quality
control while also providing the ability to monitor relative changes in ion abundances in
applications such as the diagnosis of disease.
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2.3.2 Detection of Lipids from Biological Tissue

2.3.2.1 Detection of Lipids from Mouse Brain Tissue
The lipid composition of mouse brain tissue has been extensively studied using
ambient ionization mass spectrometry (e.g. DESI)13 and therefore establishes a biological
standard by which to qualitatively measure the performance of touch spray ionization.
Using a light abrasive force and one of the probing methods described above, a small
amount of biological material from a sample can be adsorbed onto the roughened features
of the touch spray probe. To measure the TS performance, mouse brain tissue was sampled
by scratching material in small circular regions (diameter <1 mm) at different points across
mouse brain tissue sections and at each point the adsorbed material was subsequently
analyzed by a mass spectrometer. The touch spray mass spectra obtained from a transverse
mouse brain tissue section displayed in Figure 2-2 are similar to those acquired with DESI,
where signals in the negative ion mode are dominated by fatty acids (m/z < 300), fatty acid
dimers (m/z 300–700), and glycerophospholipids (m/z 700–1000). The relative abundances
of m/z 888.5 (sulfatide 24 : 1), 788.5 (phosphatidylserine 36 : 1), 834.5 (phosphatidylserine
40 : 6), and 885.5 (phosphatidylinositol 38 : 4) were used to qualitatively assess neural
composition (white and grey matter) where higher relative abundances of m/z 888.5 and
788.5 typically correspond to a higher percentage of white matter and higher relatives
abundances of m/z 834.5 and 885.5 correspond to a higher percentage of grey matter. Touch
spray was performed at six different positions in a linear path down the line of symmetry
of the tissue section with the points annotated upon the H&E stain (Figure 2-2). The touch
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spray mass spectra from the mouse olfactory bulb (Figure 2-2, point 1) displayed unique
ions detected at m/z 806.5 (PS 38 : 6) and 909.5 (PI 40 : 6) corresponding to parallel
findings using DESI.13 Similarly, the mass spectra recorded from point 2 indicated a high
percentage of white matter, corresponding to the corpus callosum. The spectra recorded at
point 5 show a high percentage of gray matter (periaqueductal gray and/or cerebellum). At
other points a mixture of gray and white matter was observed with point 3 corresponding
to the thalamus, point 4 to periaqueductal gray with white matter potentially from the
posterior commissure, and point 6 primarily white matter from the granular layer of the
cerebellum with some gray matter. The likeness in the detection of changes in lipid patterns
by TS-MS to DESI-MS corresponding to different neural compositions in different areas
of the brain signifies the high level of specificity TS-MS and other ambient techniques
have when investigating complex matrices.
The reproducibility of touch spray was assessed using coronal mouse brain
sections. These sections are comprised of grey and white matter each possessing different
relative abundances of glycerophospholipids, reflected in the spectra, and whose
distribution is symmetrical between right and left hemispheres. Touch spray was performed
at six equally spaced points across one coronal section. Mass spectra were reproducible in
terms of the prominent glycerophospholipids ions seen and also in terms of their
approximate relative intensities. They were similar between points of related neural
composition; for example, A and F indicated grey matter which produces patterns including
a base peak at m/z 834.5 and major peaks at m/z 788.5 and 885.5 whereas B and E displayed
an ion m/z 888.5 with a higher ratio of m/z 888.5 to 834.5 than m/z 788.5 or 885.5 to 834.5
indicating the presence of white matter.
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2.3.2.2 Detection of Lipids from Prostate Cancer Tissue
As discussed in Chapter 1, one of the most impactful areas of research with ambient
ionization is cancer diagnosis and methods such as DESI-MS have been to distinguish
cancer from normal tissue in human brain and other cancers. However, in the case of brain
cancer, DESI has also been shown to classify tumor subtypes, grades, and tumor cell
concentrations.14 As seen in the examples above, TS can obtain specific and reproducible
spectra from tissue. TS is being applied to prostate cancer to assess malignant and nonmalignant states. The ability to discriminate prostate malignancy from non-malignant
states is vital for improving the care of patients, and could be furthered by advances in
molecular-based diagnostics. Prostate cancer tissue from radical prostatectomy specimens
was evaluated with TS using DESI imaging in conjunction with histopathology to validate
the TS data. Samples were collected using a disposable biopsy gun and sectioned to allow
evaluation by histopathology in serial sections (<50 μm).
DESI and TS spectra acquired from a region of malignant prostate cancer,
determined by histopathology, are presented in Figure 2-3(A) and (B), respectively. The
H&E stained biopsy section shown in Figure 2-3(C) is the sample which was analyzed by
DESI imaging where the area within the black dashed line corresponds to the cancerous
region identified by pathology. The spectrum presented in Figure 2-3(B) was acquired
using TS-MS performed on an adjacent section to the DESI imaged tissue section. As
expected, the glycerophospholipid region (m/z 700–100) was observed to possess many
similarities between the two methods such as the abundance and ratio of ions at m/z 786.5,
788.5, 861.5, 863.5, and 885.5 which are tentatively identified as PS(36:2), PS(36:1),
PI(36:4), PI(36:3), and PI(38:4). The major differences seen between the TS and DESI
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spectra were the chlorinated phosphotidylcholine adducts present in the TS spectrum at m/z
values 792.5/794.5, 818.5/820.5, and 844.5/846.5 which are tentatively identified as
PC(34:2)/ PC(34:1), PC(36:3)/ PC(36:2), and PC(38:4)/ PC(38:3). The chlorinated adducts
in the TS spectrum indicate a lower salt tolerance in TS than in DESI.15

2.3.3 Detection of Therapeutic and Illicit Drugs

2.3.3.1 Therapeutic Drug Detection and Quantitation
Therapeutic drug monitoring aids in maintaining drug concentrations within the
range which is most beneficial to patient health and treatment. Drug concentrations above
the therapeutic range are often toxic to patients and concentrations below the therapeutic
range may not have any effect on treatment. Ambient ionization methods such as PS have
used whole dried blood or whole blood mixed with a coagulant to quantitatively measure
the concentrations of pharmaceuticals.16 The speed and specificity of ambient methods can
be directly applied to bedside monitoring of drug concentrations to maintain the most
effective course of treatments. Whole bovine blood spiked with imatinib, a therapeutic used
for the treatment of chronic myelogenous leukemia, and with its deuterated isotopomer
added as internal standard, were analyzed over a range of concentrations. Using the TS
teasing probe, the whole blood was sampled by dipping once directly into the spiked blood
to a fixed depth, waiting <1 min to dry after the blood coated the TS probe, and analyzed
directly after drying for detection of the drug in <2 minutes. Detection was performed in
full MS mode measuring the total ion count of imatinib to the total ion count of its
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deuterated isotopomer. The quantitative performance by TS using this methodology was
similar to that of PS when performed using MS/MS methodology which has been known
to increase performance and reduce limits of detection.10 TS had a 0.999 linear response
across the concentration range tested (Figure 2-4). These results could be increased further
using MS/MS methodology. Furthermore, the percentage error (n = 5) was <10% for
imatinib concentrations greater than 1 ppm, a value within FDA guidelines (Table 2.1). It
is envisioned that a modified TS probe may be useful as a semi-quantitative tool that could
be used as a finger-prick device which could be directly used to measure the concentration
of therapeutics in whole blood.

2.3.3.2 Illicit Drug Detection
Forensics, in particular illicit drug analysis, often requires the ability to detect
compounds in situ from matrices including powders, drug residues on surfaces including
clothing, and illicit drugs in solution. Mass spectrometry is certainly capable of analyzing
all of these types of samples when using various types of sample preparation. Touch spray
offers a rapid method by which to analyze these sample types without lengthy preparative
steps. TS can be used to probe the needed complex matrix and with the added solvent can
perform liquid-solid extraction during analysis. For instance, drug residues on clothing
typically require liquid-solid extraction using bulk solvents prior to analysis whereas with
TS the material can be lightly rubbed absorbing minute amount of drugs while removing
negligible amounts of the cloth and the solvent added to the probe can extract the drugs
during analysis for ionization and detection. This ability was demonstrated by the detection
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of cocaine from a dried blood spot containing 10 ng of the spiked drug on blue cloth. Drugs
may often be found in different complex solutions with multiple illicit drugs present, a
homogenous solution containing 400 ppb each of MDMA, cocaine, and methamphetamine
was sampled for analysis by dipping the TS probe into the solution and dried at ambient
temperature (<1 minute). The mass spectrum (Figure 2-5) was recorded by the addition of
spray solvent and a high voltage; the figure displays ions in the positive ion mode
at m/z 150.3, 194.3, and 304.3 corresponding to each of the drugs in the solution,
respectively.

2.3.4 In Vitro Detection of Bacteria
Interest in in vitro detection and identification of bacteria by mass spectrometry has
increased significantly over the past decade.17 This is due to the need for rapid detection
and identification of pathogens which may cause disease. The ability to directly detect
biomolecules such as proteins and lipids by matrix assisted laser desorption ionization
(MALDI)18 and electrospray ionization (ESI), respectively, has reduced diagnosis time
while improving accuracy due to high molecular specificity. Although these methods have
been effect, they still require sample pretreatment for analysis which can be time
consuming and labor intensive. Touch spray was investigated for its applicability to in
vitro detection with no sample preparation. A minute amount of material, as little as 1% of
a single bacterial colony, was required for mass spectral analysis. The data presented
in Figure 2-6 were acquired in the negative ionization mode with automatic gain control
(AGC) in a burst of signal lasting just a few seconds. Repeated sampling of the E.
coli culture yielded ionized lipids of identical m/z values and relative spectral intensity,
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while absolute intensity varied with sampling size. The spectra contained phospholipids in
a profile from approximately m/z 660–780, including odd-carbon number fatty acid
phospholipids (e.g. m/z 719.5, phosphatidylglycerol 32:1). It was determined empirically
that the addition of CHAPS, a surfactant, to the methanol spray solvent increased signal
and stabilized the TS spectra. Addition of CHAPS at 0.01% was determined to have the
most beneficial effect without undue interference from the CHAPS chloride adduct
(m/z 649.8). The observed surfactant effect on improving spectra in ambient ionization due
to reduction in surface tension is well known.19

2.3.5 Residual Agrochemical Detection on Foodstuff
Agrochemical is a general term for chemicals used in agriculture. Agrochemicals
include a broad range of pesticides used to attract and kill different pests including
unwanted insects, plants, and fungi. Agrochemicals are directly applied to foods in an
attempt to prolong crop quality. Many agrochemicals are toxic and pose environmental and
health risks. Oranges and other citrus fruits are commonly treated (systemically or sprayed
post-harvest) with fungicides such as thiabendazole, leaving a trace amount of material on
the surface of the orange peel. Agrochemical levels are monitored and regulated in many
countries including the United States, typically by chromatographic separation prior to MS
analysis. This procedure is not readily accomplished in situ, limiting thorough screening of
foodstuffs; however, fungicides have previously been reported to be readily detected using
paper spray ionization in situ.20 Similar to the use of ambient ionization in bedside use for
monitoring therapeutic drugs, the features of TS and other ambient methods may be able
suitable for the improvement of monitoring of agrochemicals for food safety.
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A non-organic orange purchased from a national grocer was subjected to analysis
by TS, in which the probe was used to sample a 4 cm2 area of the peel. The spectrum,
Figure 2-7, includes ions due to protonated thiabendazole (m/z 202) and imazalil (m/z 297).
When the method was applied to an organic orange, fungicides were not detected. The
acquired spectrum matches previously reported fungicides detected from non-organic
oranges using an alternative ambient ionization method (i.e. low temperature plasma).21

2.3.6 Reactive Touch Spray
TS-MS experiments exploiting simultaneous chemical derivatization and
ionization (i.e. reactive ambient ionization) were explored. Derivatized versions of analytes
often give greater signals in MS analysis of complex mixtures. The use of appropriate
reagents allows reduction of complex spectra via analyte signal enhancement or
characteristic m/z value shifts. Chemical derivatization advantages also extend to detection
of classes of analytes which may not readily ionize using ambient ionization techniques.
Reactive touch spray was explored with known types of ambient reactions including noncovalent adduct formation, (e.g. silver adduction of olefins22) and covalent bond formation
(e.g. betaine aldehyde with alcohols23). Cholesteryl linoleate and adrenosterone were
separately sampled and chemically derivatized from unique homogenous solutions using
the dip sampling method and spray ionization using TS. The unsaturated aliphatic
functionality of cholesteroyl lineolate reacted with silver nitrate (4 ppm, dissolved in
acetonitrile) forming non-covalent adducts detected at m/z 755.4 and 757.4 corresponding
to [cholesteroyl lineolate +

Ag] and [cholesteroyl lineolate +

107

Ag]. Covalent bond

109

forming reactions targeting the ketone functional group in adrenosterone, a cholesterol-
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related hormone, were accomplished using Girard's Reagent P and hydroxylamine. The
detection of cholesterol from bovine blood was accomplished using betaine aldehyde
which reacts with a poorly ionizable hydroxyl functionality creating a positively-charged
quaternary amine derivative. It is envisioned that using a combination of chemical
derivitization techniques could be used to measure total cholesterol levels in blood which
includes detection of low-density lipoprotein, high-density lipoprotein and triglycerides all
which can be detected using a combination of the described chemical derivitization
methods above.

2.4

Conclusions

Touch spray (TS) ionization is a spray-based ambient ionization method capable
of in situ sampling of complex mixtures. Rapid, reproducible, and specific chemical
information is obtainable from biological tissue including mouse brain and human prostate
cancer. Differentiation of specific anatomical regions and disease states based on lipids
detected in the negative ionization mode appears to be possible. TS-MS of complex
solutions, including whole blood, could allow for numerous applications in forensics
(e.g. illicit drug detection) and medicine (e.g. therapeutic drug monitoring). Application in
the detection of pathogens including bacteria is promising, the detected lipids allowing for
differentiation of bacteria which may be useful in clinical or environmental settings. Use
in environmental settings can be expanded to the detection of agrochemicals on foodstuffs
or the crop bed to reduce human exposure to the toxicity of harmful pesticides. The userguided nature of TS allows for the unique sampling abilities while potentially limiting
absolute quantitation. Further, as is the case for many ambient ionization techniques,
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simultaneous ionization and chemical derivatization enhances the signal for specific
analytes or groups of analytes.
Further development of TS-MS including the sampling methodology, probe design,
and probe material could lead to improved quantitative performance and reproducibility.
The ultimate application of the TS technology would be in combination with miniaturized
mass spectrometer systems to allow for in situ sampling, ionization, and mass analysis.
The successful detection of lipids from complex biological matrices including
mouse brain and human prostate cancer tissue and the similarities of those detected lipids
and patterns to those of established techniques such as DESI provides the basis for further
investigation of TS-MS as a potential in vivo surgical tool for disease diagnosis. Chapter 3
will discuss the concurrent study of human prostate cancer with the established technique
DESI and the investigated technique TS.
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Table 2.1 Calculated percent errors in the calibration curve for imatinib
Imatinib Concentration (ppm)
1.00
1.67
3.33
6.67
13.3

Percent Error (%)
8.94
0.688
0.309
1.62
-2.05
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Figure 2-1 Methods of sampling different complex matrices such as A) solid matrices
(tissue) and B) liquid matrices (whole blood). Process of spray ionization shown in C)
where the orientation of the TS probe to the inlet capillary and the addition of solvent and
high voltage induce electrospray processes and the formation of charged droplets.
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Figure 2-2 H&E stained transverse tissue section of mouse brain displayed in the (top left)
with annotated positions from the anterior to the posterior of the section. Sampling point 1
located in the (bottom left) corner displays a representative spectrum obtained from the
olfactory bulb which contained a unique lipid pattern dissimilar from the other points of
the brain. Spectra located on the (right) correspond to the annotated points and measure
varying levels of white and grey matter in the brain.

41

Figure 2-3 Spectra taken from adjacent tissue sections of the malignant region of a prostate
biopsy section with A) corresponding to DESI-MS analysis and B) corresponding to TSMS analysis. C) Corresponds to the DESI analyzed biopsy section with pathological
evaluation of prostate malignancy outlined by the dashed black line.
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Figure 2-4 TS-MS calibration curve obtained from repeat analysis (N = 5) of imantinb from
whole bovine blood in full scan positive ion mode. Data points were obtained from 1 to
13.3 ppm, error bars correspond to the standard deviation of the 5 repeat analyses, and the
linear regression was performed using unweighted least squares analysis.
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Figure 2-5 TS-MS of illicit drugs (methamphetamine, MDMA, and cocaine) detected from
a homogenous solution with each drug at 400 ppb concentrations. Drugs were detected
using a single sampling of the solution using the dip method.
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Figure 2-6 E. coli. negative ion mode mass spectrum obtained by TS-MS from a sampling
of <1% of a single colony. Along with the glycerophospholids from the bacteria, the
chloride adduct of the surfactant added to the spray solution (CHAPS) was also detected.
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Figure 2-7 Positive ion mode mass spectrum of fungicides thiabendazole and imazalil
detected by TS-MS from wiping a non-organic orange purchased from a nation grocer.
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CHAPTER 3.
DIFFERENTIATION OF PROSTATE CANCER AND NORMAL
PROSTATE TISSUE BY DESORPTION ELECTROSPRAY IONIZATION
AND TOUCH SPRAY IONIZATION MASS SPECTROMETRY USING
RADICAL PROSTATECTOMY SPECIMENS

3.1

Introduction

Prostate cancer has been estimated to be diagnosed in the United States over
233,000 times in 2014, more than any other diagnosed cancer cases.1 Treatments for
prostate cancer include surgery, radiation therapy, and hormone therapy, the choice
between them being primarily dependent on the patient's health and the stage of the cancer.
At the time of diagnosis, over 90% of prostate cancer cases have tumors confined to the
prostate gland. Before cancer has spread to the outer layer of the prostate, the disease is
potentially curable through complete surgical resection.2 Standard practice relies on
preoperative measurements such as rectal examination and clinical biopsy data to guide
surgical resection. Typically, positive surgical margins are only identified after completion
of the surgery and have been reported to occur >30%.3
Needle biopsies are used for early diagnosis of prostate cancer, however this
method is prone to false negatives, reportedly up to 25%.4 Difficulty in diagnosis from
needle biopsy is the result of limited sample size, limited number of malignant glands
among many benign glands, and confusion of benign histological features which mimic
prostate cancer such as paraganglia or xanthoma. Immunohistochemistry (IHC) is often
used to label p63, a marker for basal cells, which is present in benign and absent in
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cancerous tissue. However, negative staining is not always reliable.5 Currently
unrepresented in prostate diagnostics is the use of the lipid constituents of tissue, either in
early diagnosis or in post-surgical tumor margin diagnostics.
As discussed in Chapters 1 and 2, lipid constituents of tissues are readily detected
by ambient ionization MS methods such as DESI-MS6 and TS-MS.7 Rapid evaporative
ionization mass spectrometry or REIMS is a newly developed ambient ionization method
by Takáts and coworkers used to study lipid constituents from tissues.8 This technique
analyzes the smoke produced from electrosurgical dissection of tissue by transferring the
smoke to a mass spectrometer through Teflon tubing using an air jet pump. Currently, the
method is aimed to use smoke produced during electrosurgical dissection during surgery
for near-real time tissue identification. Challenges with this method may occur when trying
to obtain exact pathology on tissue analyzed as the method is extensively destructive. DESI
and TS, as discussed in previous Chapters, are spray based ambient ionization methods.9
DESI imaging has been shown to be morphologically compatible, therefore using specific
solvent systems allows for histopathological evaluations to be performed on the exact
tissue which has been imaged.10 TS, similar to REIMS, is also a destructive method and
loses exact pathology information in the exact region analyzed, but TS has been
demonstrated to give near identical mass spectra to DESI on tissue analyzed from the same
regions on adjacent tissue sections.
DESI and TS both produce information rich spectra which are specific and
reproducible to tissue features, as discussed in Chapters 1 and 2. These qualities, also as
previously discussed, have been shown to be useful in the detection of molecular patterns
corresponding to disease which may be useful in pathological evaluations.7 However, the
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differences between how these methods are performed may make them suitable for
different tasks. To elaborate, DESI-MS is primarily an imaging technique, allowing
collection of mass spectra, pixel by pixel, to create 2D molecular images. The collected
data can be assembled in hyperspectral datacubes11 from which 2D ion images
corresponding to specific components can be extracted to show the spatial distribution and
relative amounts of analytes. Applications of DESI in distinguishing diseased and nondiseased tissue rely on the use of multivariate statistics,11 typically principal component
analysis (PCA) and linear discriminant analysis (LDA). DESI provides a key connection
between the information from histopathology and the characteristic mass spectrum that is
produced for each tissue and disease type because the same (or adjacent) tissue sections
analyzed by DESI can be evaluated by the pathologist. On the other hand, TS-MS is a userguided method in which a spot of interest is directly sampled with a probe, e.g. teasing
needle, and transferred to the interface of a mass spectrometer, and ionized by the
application of solvent and high voltage. TS produces information rich spectra which are
similar to DESI, but in a localized and very rapid process which typically takes a few
seconds.
This Chapter explores the potential of DESI-MS and TS-MS for prostate cancer
differentiation through in vitro analysis of radical prostatectomy specimens. First, DESIMS was used to establish the relationship of MS features to pathology and then touch spray
was used to characterize unknown tissue samples. Training sets for both methods were
built using data obtained from 12 radical prostatectomy specimens and evaluated by PCA
and linear discriminant analysis (LDA). Both methods resulted in >95% correct sample
identification when confirmed against histopathology. A TS-MS evaluation dataset,
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obtained from another six radical prostatectomy specimens, was used for further
assessment of the method by taking a non-targeted approach for the MS and statistical
analysis of the prostate tissue samples. Lastly, the predicted tissue disease states were
compared to histopathological results.

3.2

Experimental

3.2.1 Study Protocols
Radical prostatectomy specimens #1–19 were obtained from consented patients
undergoing treatment at Indiana School of Medicine (Indianapolis, IN) following an IRB
approved study. Biopsies were obtained from specimens #1–18 after resection using a
disposable biopsy gun (Max-core disposable core biopsy instrument, Bard Biopsy Systems,
Tempe, AZ). Biopsies (approximately 4–15 mm × 1 mm × 1 mm) were subsequently
frozen, cryosectioned at 15 μm, and thaw mounted to glass microscope slides. Sections
were stored at −80 °C prior to MS analysis. The same slide analyzed by DESI-MS imaging
was H&E stained and examined by an expert pathologist to identify from tissue
morphology the presence/absence of prostate cancer. Adjacent sections (separated by 15–
60 μm) were analyzed by TS-MS by sampling areas of 1–4 mm2 from regions of known
pathology based on the DESI/histopathology assignment of locations as diseased or normal
tissue. Note that this procedure was necessary because TS is a destructive sampling method
for thin sections. Radical prostatectomy specimen #19 was inked according to IUSM gross
pathology protocol then bisected to allow the tissue to be analyzed in vitro. The specimen
was analyzed by TS-MS at IUSM using an on-site commercial mass spectrometer. No
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biopsies were taken from specimen #19 and thus no DESI-MS analysis was performed.
Radical prostatectomy specimen #19 results were compared to gross pathological analysis
obtained from IUSM.
A total of 100 samples were prepared from patients # 1–12 and used to create a
database of tumor and normal tissue mass spectra for both DESI and TS methods. These
databases are referred to as targeted datasets, because the data used is directly correlated
with histopathological analysis of the tissue. For the DESI targeted datasets, regions
outlined as tumor or normal by pathology were selected (4 mm2 on average) and data were
averaged to create each data point for subsequent multivariate analysis. In parallel, TS was
performed in the regions outlined as tumor or normal tissue from adjacent tissue sections
used for DESI and that data was directly used to create the TS targeted dataset. Table
3.1 shows in detail the number of sections prepared per biopsy and patient. Another 70
biopsies were prepared from the other 6 radical prostatectomy specimens (patients # 13–
18) and these were analyzed only by TS-MS to create an evaluation dataset to further test
performance. Table 3.2 details the section or sample number and then the relation to patient
and biopsy. The biopsy sections used to create this independent evaluation dataset were
randomly chosen and sampled 1–2 times (depending on the size of the tissue) to create a
110 sample dataset. Also included in the evaluation set were 1–2 randomly selected
samples from each patient used in the targeted dataset. Histopathology of these tissue
sections was performed after MS analysis on adjacent tissue (spacing 15–60 μm).
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3.2.2 Ambient Ionization Techniques

3.2.2.1 DESI-MS
A laboratory-built DESI ion source, similar to the commercial 2D source from
Prosolia, Inc. (Indianapolis, IN, USA) was coupled to a linear ion trap mass spectrometer
(LTQ) controlled by XCalibur 2.0 software (ThermoFisher Scientific, Waltham, MA) and
used in DESI experiments. The negative ionization mode was used with the automatic gain
control (AGC) inactivated. The spray solvent used for DESI-MS was dimethylformamide
(DMF)–acetonitrile (ACN) at a 1:1 ratio (v/v), both solvents were purchased from
Mallinckrodt Baker Inc. (Phillipsburg, NJ), and delivered at 1.0 μL min−1 flow rate using
the instrument syringe pump. The DESI source parameters were set as follows: capillary
temperature 275 °C, voltage applied to the stainless steel needle syringe 5 kV, capillary
voltage −25 V, tube lens voltage −115 V, capillary incident angle 54°, spray to surface
distance 3 mm, sample to inlet distance 5 mm, and nitrogen gas at 180 PSI. Prostate tissue
sections were analyzed using a moving stage with a lateral scan rate of 303.03 μm s −1 in
horizontal rows separated by a 200 μm vertical step. Instrument scan time was coordinated
with scan speed providing 200 × 200 μm pixels. DESI spot size approximately 350-500
μm. Full scan mass spectra were acquired in negative ion mode in the mass range m/z 200–
1000. For statistical analysis of the evaluation dataset, a reduced mass range of 700–1000
was used, limiting the biochemical information to complex phospholipids.
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3.2.2.2 TS-MS
The TS probe used was a commercially available teasing needle purchased from
Fisher Scientific (Pittsburgh, PA, USA).7 Methanol (Mallinckrodt Baker Inc., Phillipsburg,
NJ) was used as spray solvent and 1 μL was applied manually via an adjustable pipette
(Eppendorf Research-2.5 μL). The LTQ linear ion trap mass spectrometer was also used
for the TS experiments with the same operating parameters as those used in the DESI
experiments except that the voltage applied to the TS probe was 4 kV and the automatic
gain control was active. TS was performed by touching and desorbing material onto a
teasing needle from regions of interest of 1–4 mm2. After sampling, the tip of the probe
was directed at the inlet of the mass spectrometer and the high voltage and 1 μL of solvent
were applied. The extracted analytes were analyzed in a spray time of 6 seconds. The data
acquired within this period were averaged to represent a single data point.

3.2.3 Multivariate Statistical Methods

3.2.3.1 Principal Component Analysis
An in-house program was used to convert the MS data files (.raw) into ASCII files
(.txt), which were imported into Matlab (MathWorks, Inc., Natick, USA). Biomap software
(http://www.maldi-msi.org) was used to display single ion images (i.e. spatial distribution
of a single m/z variable, Figure 3-1) with MS intensity represented in false color
(normalized to the absolute value). For each DESI image, information was coded as a
datacube (X·Y·MS), where “X” and “Y” are spatial dimensions and the “MS” domain
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contains the m/z variables and corresponding intensity (i.e. an entire mass spectrum).
Groupings of adjacent pixels,i.e. regions-of-interest (ROIs), representing areas of tumor or
normal tissue were selected in the 2D spatial domain (X·Y), according to pathological
evaluations, and the corresponding mass spectra were averaged. The averaged mass spectra
from the prostate sections constituted the DESI target dataset. The TS target dataset was
built using a list of m/z values and ion abundances from the average mass spectrum (over 6
s of data acquisition) acquired per sample. The data were then imported into Matlab.
The acquisition step used to increment m/z values was equal to 0.0833, therefore
the two data matrices (DESI and TS) consisted of 3601 columns (i.e. m/z values) and 100
rows (i.e. samples: normal tissue sections, n = 74; tumor tissue sections, n = 26). PCA was
performed with in-house Matlab routines. PCA is commonly used for exploring complex
information contained within mass spectral datasets, allowing consideration of all spectral
variables and possible inter-correlations simultaneously.11,12 By means of PCA, the
information of the original m/z variables is reorganized and compacted in a few principal
components (PCs). That is, PCA can be used as an unsupervised data compression
technique. When dealing with high-dimensional data, the compression of the relevant
information is a preliminary step in order to efficiently manage and extract useful features.
All MS spectra were normalized by the standard normal variate (SNV) transform,
correcting for both baseline shifts and global intensity variations,13,14 and then column
centered. The principal components are orthogonal (i.e. uncorrelated) and efficiently
describe large fractions of the information. The projections of the data objects onto the PCs
are called scores, while the importance of each original variable in defining a certain PC is
given by a loading coefficient. Groupings in the score plot indicate similarities among the
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objects (i.e. samples), based on the information derived from the mass spectra. Both scores
and loading values were represented in two-dimensional scatter plots.

3.2.3.2 Linear Discriminant Analysis
Linear discriminant analysis (LDA) was performed as a supervised discriminant
classification technique. Discriminant methods look for a delimiter that divides the global
domain into a number of regions, each assigned to one of the classes.15,16 This delimiter
identifies an open region for each class and such regions determine the assignment of the
samples to one of the classes. Model validation (i.e. evaluation of the predictive ability of
the model) was performed by means of cross validation (CV).16 For this study, five crossvalidation deletion groups were selected, meaning that all the samples (n = 100) were
divided five times systematically in a training set (objects used for building the
classification model, n = 80) and a test set (remaining objects used to evaluate the
predictive ability of the model, n = 20), with all the samples being in the test set only once.
Eventually, the final model was built using all the objects. LDA was applied on the DESI
and TS target datasets of SNV normalized mass spectra after compression by PCA, thereby
using as variables the principal components (instead of the original mass spectral data).
Two classes were modelled: normal tissue (n = 74) and tumor (n = 26). In more detail, 8
PCs for DESI and 9 PCs for TS were computed each time with the training samples and
used for building the classification model. The test sets – samples that did not contribute
in the model building process – were used to estimate the global prediction rate for all
classes, hence as the CV prediction rate for each class. This is a so-called complete
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validation strategy.16 The CV prediction rate is the percentage of correct predictions on the
objects in the CV test sets. The CV confusion matrix shows how many samples belonging
to a certain category were correctly/incorrectly assigned by the classification rule to that
category. Indeed, in this matrix, each element gives the number of samples of the row
category assigned to the column category. When the matrix is diagonal (entries outside the
main diagonal are all zero) there is a perfect prediction of all the samples. Note that LDA
models used for supervised discriminant classification were built by using 4 to 10 PCs. The
models with 8 and 9 PCs, for DESI and TS respectively, were chosen as they provided the
least number of false results (i.e. highest prediction rates) in cross-validation.
The model built for the TS dataset was used further to predict the normal/disease
state of another 110 samples (the evaluation set), whose histopathology was unknown at
the time of MS analysis. The subsequent comparison between molecular diagnosis by TSMS and histological diagnosis further validated the TS-MS model performances. LDA was
performed with Matlab using in-house routines.

3.2.3.3 Canonical Correlation Analysis
Canonical correlation analysis (CCA) is a way of measuring the linear relationship
between two multidimensional variables (DESI and TS) observed on the same sample
collection.17,18 In this study, the two datasets represent the DESI and TS mass spectra
recorded from 100 prostate tissue sections. The DESI mass spectral dataset is considered
as a reference. CCA rotates the original variables in the two blocks, to obtain some pairs
of variables (one for each block), called canonical variables, with maximum correlation
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between the two blocks. The dimensionality of these new bases is equal to or less than the
smallest dimensionality of the two sets of variables. The canonical variables are linear
combinations of the original autoscaled (i.e. unitary variance) variables, whose
contribution in defining a specific canonical variable can be inferred through the
corresponding loading value. The correlation coefficients between the DESI canonical
variable and the corresponding TS canonical variable are termed canonical correlation
coefficients. Specific details on CCA can be found elsewhere.17,18 In order to overcome the
high inter-correlations across m/z values, CCA was performed after PCA, which acts as an
unsupervised data compression technique. Two separate PCAs were run on the SNV
normalized and column-centered DESI and TS mass spectral data. The first 10 PCs,
explaining about 90% of total data variation, were selected and used for CCA. CCA was
performed by the free chemometric package V-PARVUS 2010 (University of Genova,
Italy, (http://www.csita.unige.it/software/free/other.html).

3.3

Results and Discussion

3.3.1 DESI and TS Lipid Patterns and Training Sets
Prostate cancer is a heterogeneous disease diagnosed by histopathology. Diagnosis
is based on morphological variations which are a result from underlying biochemical
changes. The two main criteria used by histopathologists for diagnosis are atypical
architectural features (e.g. perineural infiltration) and atypical cytological features
(e.g. enlarged nuclei). Typical diagnosis of prostate cancer uses these features and IHC
staining of specific proteins, but does not currently use the lipid constituents of the tissue.

57
In this study, two different ionization techniques, DESI and TS, were used to acquire lipid
profiles of prostate cancer and normal tissue and subsequently those profiles were used to
differentiate the two different disease states of the tissue.
The lipid constituents which were used to investigate disease state are primarily
glycerophospholipids: phosphotidylethanolamines (PhE), phosphotidylserines (PhS),
phosphotidylcholines (PhC), and phosphatidylinositols (PhI). These lipids can be observed
in the average normal (74 samples) and tumor (26 samples) mass spectra shown in Figure
3-2 for DESI (A and B) and TS (C and D). Differences between the lipid profiles of prostate
cancer and normal tissue are subtle. Many small changes in relative ion intensities of
specific ions and a few completely different lipid constituents are seen with small ion
intensities can be seen when comparing the spectra of different disease states. Most of the
same changes between prostate cancer and normal tissue are seen in both DESI and TS
spectra. These changes include ratio changes for ions m/z 788 and 885, an increase in
relative abundance of ions m/z 786, 835, 861, 863, and a decrease in relative abundance of
ions such as m/z 737. Despite similarities between TS and DESI methodology and spectra,
there are also differences in their average mass spectra (Figure 3-2A vs. D, Figure 3-2B vs.
E). For example, chlorinated adducts of phosphatidylcholine species (e.g. m/z 794) are
more abundant in the TS spectra than in the DESI spectra. Some of these chlorinated
adducted species, like m/z 794, are also useful in differentiation of prostate cancer and
normal tissue. The addition of the chlorinated adducts in the TS spectra suggests that some
differences between the ionization methods can be attributed to different salt content
tolerances, which has been previously reported.19 The spectra from Figure 3-2 also displays
other information that reflects differences between TS and DESI, average ion intensity in
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TS is two orders of magnitude greater than that in DESI, suggesting that
extraction/desorption occurs more rapidly in comparison to DESI. Considering all of the
lipid profiles recorded for the entire training dataset, 12 patients and 100 samples
(thousands of mass spectra), the differences between disease states are difficult to address
by eye. Therefore, a robust statistical strategy is needed to efficiently explore the chemical
information contained in the mass spectra. PCA was performed as an unsupervised
exploratory tool to identify chemical features that characterize prostate cancer and normal
tissue based on the DESI and TS lipid profiles corresponding to those disease states. 2dimensional PCA score plots are shown in Figure 3-3A and B for DESI and TS,
respectively. Both 2D plots display the lowest-order principal components (PCs) for which
separation between normal and tumor tissue is apparent, however separation occurs
multidimensional. Distinct separation and groupings of normal (dark green objects) and
tumor tissue samples (red objects) can be observed from these plots. The 2D loading plots
shown in Figure 3-4A and B display those lipids that contribute the most to each PC.
The first principal component by definition encompasses the largest variation in the
multidimensional space of the original variables, PC2 is orthogonal and includes the largest
remaining variation, and the same is true for PC3 and on until all variation is accounted
for. The separation seen in PC space between prostate cancer and normal tissue is due to
the reproducible differences between their DESI (and TS) mass spectra (i.e. lipid profiles
specific to disease state). The TS spectra are usually more complex than the DESI spectra,
which may be attributed to inherent differences in the recorded spectra (e.g. chlorinated
adducts of PhC species). Due to the noisier spectra, the best separation among red and dark
green objects in PCA space for TS is in the PC3 vs. PC4 score plot or 19.6% of the variance.
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By contrast, DESI mass spectra result from averaging many pixels in the hyperspectral
images, selected as regions of interest (prostate cancer or normal tissue) and this helps
reduce random noise. In DESI, the best separation is along PC2 vs. PC3 or 22.8% of the
variance. The additional complexity in the TS spectra adds additional complexity to PCA,
resulting in TS score plots having lower total variation of the data explaining the separation
of prostate cancer and normal tissue than DESI does.
The loading plots which correspond to the best separation of disease states for DESI
and TS also display a similar relationship between the variables (m/z values) that contribute
to either the diseased state or healthy state. This observation provides initial insight into
the consistency between DESI and TS in recovering the same biochemical features
associated with a disease state. Variables consistent between both methods based on
statistical examination are ions m/z 835, 861, 885, and 887 which higher in relative
abundance in prostate cancer tissue and m/z 788 which is higher in relative abundance in
normal prostate tissue.

3.3.2 Classification of Prostate Cancer and Normal Tissue using Lipid Profiles
LDA was performed on the DESI and TS targeted datasets (selected data which
correlated to identified tumor or normal samples by histopathology) to quantify the PCA
separation between prostate cancer and normal samples. The first eight and nine PCs were
used for DESI and TS datasets, respectively, which correlated to ~90% of the total variance
of each dataset (this provided the highest prediction rates for both prostate cancer and
normal classes by reducing the additional noise that makes up the last ~10 of total
variance). The average cross-validation (CV) prediction rate was 98% for DESI and 96%
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for TS. The CV confusion matrices, Table 3.3, report the number of false results per class
(prostate cancer and normal) obtained through the cross-validation process. DESI performs
slightly better than TS-MS, which is expected due to the reduction of noise by averaging
of many more spectra as discussed above, although both methods exceed 95% in correct
predictions.
TS-MS is envisioned to be used as previously discussed in Chapters 1 and 2 as an
intraoperative tool to help surgeons rapidly determine disease state information. To test the
potential performance of TS-MS, an additional evaluation set was tested using a nontargeted approach, mimicking a true surgical setting. Samples were acquired from patients
#13–18 and a total number of 70 biopsies were performed from which 110 samples were
analyzed randomly, prior to any pathological evaluation. The PCA-LDA model built on
the targeted TS dataset was used to predict the tissue condition (tumor or normal) of these
unknown samples. The LDA predictions, based on MS molecular diagnosis, were finally
compared with pathological evaluation of adjacent tissue sections to those analyzed.
Pathology diagnosed nine samples as prostate cancer and the remaining 101 samples were
diagnosed as normal tissue. The PCA-LDA results were only moderately discriminatory
which we attribute to the low reproducibility of some ions (e.g. chloride adducts) and the
effect of this reproducibility as well as complication from ions which do not contribute to
any disease state when applied to PCA analysis. We therefore built a supervised LDA
model using the top five discriminant ions in the range m/z 700–1000, as opposed to
compressing the entire mass spectra by PCA, using a stepwise variable selection strategy
to select the most discriminant ions.15 This strategy proved more efficient and robust in
differentiating tumor and normal tissue for the TS targeted dataset. Table 3.4 displays the
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results of the supervised method, with no prediction errors in cross validation. Moreover,
the average percentage of correct prediction of tumor and normal tissue for the external
evaluation set (110 samples) was equal to 93%. It should be noted that the small number
of samples with tumor tissue was due to the non-targeted selection of the samples analyzed
and that because one of the nine prostate cancer samples was misclassified the entire
predication rate for both classes suffered. The overall prediction rate for the normal
samples was 96% and it is expected that an increase in numbers of prostate cancer nontargeted samples would increase the overall prediction rate to a higher percentage, similar
to that of the normal prediction rate. The improvement in statistical evaluation from an
unsupervised method to a supervised method suggests that further refinements of the
strategy used for data analysis could strengthen a decision-making strategy based on
molecular diagnosis. A wide portfolio of pretreatment processes and variable selection
techniques is available for pattern recognition analysis, following the needs of the acquired
MS data structures.

3.3.3 DESI and TS: Similarities and Outlook
Since DESI imaging records spectra in pixels across all of an imaged area, it can
be used to directly correlate lipid profiles to pathology and MS analysis can be performed
before prior to pathology. TS on the other hand investigates a single point, thus TS needs
some information prior to being performed (e.g. pathology on adjacent tissue when
building a library or a previously built TS-MS library to be used for disease prediction).
Thus, similarities between DESI and TS mass spectra in providing chemical features
associated with a healthy or diseased state is of interest, because DESI can then be
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performed and used as a basis for subsequent TS analysis on adjacent tissue. Although
based on similar mechanisms of ion generation (i.e. electrospray-like mechanisms), DESI
and TS have been shown above to produce mass spectral features with some similarities
and some differences, but key features to disease states seem to be consistent. Since
diagnosis capabilities seem to be similar from the targeted datasets, the differences in how
the techniques are performed may determine the techniques to be used in their own fit-forpurpose strategies for molecular diagnosis.
To estimate the similarities or correlation between the two sets of targeted MS data,
canonical correlation analysis (CCA) was performed for DESI and TS. Figure 3-5 shows
the samples in the canonical variable space (1 vs. 2) for DESI and TS with a clear separation
between prostate cancer (red) and normal tissue samples (dark green). The correlation
coefficients for the first three canonical variables are 0.94, 0.76, and 0.68 respectively
(Figure 3-6). The high correlation between DESI and TS is also supported by the location
of each data point (labelled with the same data point number corresponding to specific
samples in both plots) in the CCA space. For example, prostate cancer data point number
98 can be seen in the far left middle region of both plots and the normal data point number
74 can be seen in the bottom right corner region of both plots. The loading plots (Figure 37) show the greatest contribution to the canonical variable computation from principal
components 1, 2, and 3 for DESI and principal components 2, 3, and 4 for TS. The
differences between the PCs which correlate to the canonical variable computation for
DESI and TS is due to the fact that the principal components that carry the biochemical
information relevant to separating tumor and normal tissue samples are 1, 2, and 3 for
DESI, but 2, 3, and 4 for TS.
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The CCA results suggest that the chemical features present in DESI and TS spectral
patterns which correlate to prostate cancer and normal tissue are consistent between
methods. These results suggest that both methods will have similar diagnostic performance,
but with different, possibly complementary, diagnostic implementations based on the how
the technique is performed as now discussed. Some of the most important features of TS
is its use of the probe as a means of a user guided sampling tool and as the tool which
serves as the source where a spray is induced to produce ions for mass spectral analysis.
TS has been previously reported to produce spectra from a variety of samples and is not
limited to tissue sections, but can be used to investigate areas of interest in vivo.7,20 Figure
3-8 shows the degree of similarity of (A) a TS mass spectrum obtained by sampling a
bisected radical prostatectomy specimen in vitro and (B) a TS mass spectrum obtained
from a frozen tissue section from the training set. TS is an extremely rapid technique, where
the total time from initial sampling to final data collection can be within 20 seconds or
longer depending on the transfer time step where the sample could be directly next to the
mass spectrometer or in another room, building, etc. DESI imaging on the other hand is
only performed on tissue sections or thin films of tissue material such as tissue smears21
and allows for collection of mass spectra, pixel by pixel, to create 2D molecular images.
Single 2D ion images can be made from assembled hyperspectral datacubes containing the
2D spatial information with a third dimension of each mass spectrum. The 2D ion images
correspond to specific m/z components and can be extracted to show the spatial distribution
and relative amounts that analyte.
Limited sample size is the main disadvantage of TS-MS. The minimal removal of
material from a sensitive source such as tissue is viewed as an advantage for the patient,
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but it limits the power of the technique by reducing analysis to a few MS scans before the
signal is exhausted. This could be overcome by multiple examination of the same area, but
each additional sampling requires more time. The limited sample size collected by the TS
probe also forces the user to carefully consider the measurement uncertainty due to
sampling, which may bias the analytical results. Time may be the main disadvantage for
DESI imaging. Time is required for the minimal sample preparation to produce tissue
sections or smears and is required for each pixel taken within an image. Higher spatial
resolution for images and higher mass resolution for mass spectra can make MS images
take hours, but depending on the number of pixels and mass resolution needed some images
can be performed in minutes.
Due to the TS-MS features and performance, this technique is envisioned as a
surgical tool for disease screening of areas of interest. As a surgical screening tool, TS
could help preserve healthy tissue that may have otherwise been resected for
histopathological evaluation or help with decisions to remove additional diseased tissue
that was observed to be questionable. DESI imaging features and performance make this
technique to be envisioned for use as a supplemental and orthogonally complementary
technique for pathological evaluation of tissue sections. This could help with absolute
pathology on tissue and provide understanding not only of morphological changes, but of
the underlying biochemical changes which may explain the morphological changes. DESI
is also being further developed outside of imaging methodologies and may also play a role
in intraoperative settings like TS.22
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3.4

Conclusions

DESI-MS and TS-MS have been used to successfully differentiate prostate cancer
and normal tissue using biopsies taken from 18 radical prostatectomy surgical specimens.
The targeted datasets (radical prostatectomy specimen 1–12) were subjected to
discriminant classification analysis using PCA-LDA. Average prediction rates of 97.5%
for DESI-MS and 96% for TS-MS were obtained using this type of unsupervised statistical
analysis. The validation of TS-MS as a non-targeted technique which may be used in a
surgical setting was performed using an external evaluation set (radical prostatectomy
specimen 13–18) of unknown disease states of prostate specimens. These unknown
specimens were randomly surveyed using TS-MS and the non-targeted data sets were
analyzed using supervised statistical methods which provided average predictions rates of
92.5%, though this percentage is thought to be improved with a larger dataset, specifically
prostate cancer samples. DESI and TS results are comparable (0.94 correlation coefficient
by CCA), recovering similar biochemical information, primarily glycerophospholipids,
that are responsible for the separation of prostate cancer and normal prostate tissue
samples.
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Table 3.1 Samples for DESI and TS targeted datasets
Patient #
1
2
2
3
3
4
4
4
4
5
5
5
5
5
5
5
5
5
6
6
6
6
6
6
6
6
6
6
7
7
7
7
7
7
7
8
8
8

Biopsy #
6
3
2
9
7
3
6
9
7
1
2
3
4
5
6
7
8
9
1
2
3
4
5
6
7
8
9
10
5
6
7
8
10
12
14
2
3
4

Sample # DESI:TS
2:8
6:3
3:6
5:6
6:3
6:4
6:3
5:7
2:4
3:1
5:3
5:4
7:4
3:4
5:3
6:3
2:7
5:4
5:2
5:3
7:3
4:7
4:6
3:7
7:8
8:6
7:4
5:4
6:7
3:4
4:5
4:5
3:4
5:4
3:4
6:5
5:6
6:7

Diagnosis
Tumor
Tumor
Normal
Tumor
Normal
Tumor
Tumor
Tumor
Normal
Normal
Normal
Normal
Normal
Normal
Tumor
Normal
Normal
Normal
Normal
Tumor
Normal
Tumor
Normal
Tumor
Tumor
Tumor
Tumor
Tumor
Normal
Normal
Normal
Normal
Normal
Tumor
Normal
Normal
Normal
Normal

Gleason Scorea
(3+4)7
(3+4)7
(3+4)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+5)9
(4+5)9
(4+5)9
(4+5)9
(4+5)9
(4+5)9
(4+5)9
(4+5)9
(4+5)9
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(3+4)7
(3+4)7
(3+4)7
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Table 3.1, Continued
Patient #
8
8
8
8
8
8
8
8
8
8
9
9
9
9
9
9
9
9
10
10
10
10
10
10
10
10
10
10
10
10
10
10
11
11
11
11
11
11
11

Biopsy #
5
6
7
8
9
10
11
12
13
15
3
7
8
10
13
14
15
17
1
2
3
4
5
6
8
9
10
11
12
13
14
16
1
2
3
4
5
7
8

Sample # DESI:TS
3:4
5:6
7:6
5:4
7:6
5:4
3:4
7:6
6:5
4:6
4:5
6:7
6:5
5:4
6:7
3:2
6:5
3:4
7:6
5:6
6:5
4:3
6:7
4:5
6:7
4:5
6:5
6:7
5:6
7:6
4:3
6:7
5:4
4:5
5:6
6:5
7:5
6:5
5:4

Diagnosis
Normal
Tumor
Normal
Normal
Tumor
Tumor
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Tumor
Normal
Normal
Normal
Normal
Tumor
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Tumor
Tumor
Normal

Gleason Scorea
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+5)9
(4+5)9
(4+5)9
(4+5)9
(4+5)9
(4+5)9
(4+5)9
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Table 3.1, Continued
Patient #
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
12
12
12
12
12
12
12
aGleason

Biopsy #
9
10
11
12
13
15
16
17
18
20
21
22
23
24
25
27
2
7
8
9
10
13
15

Sample # DESI:TS
4:5
5:4
5:6
4:5
5:4
5:4
5:4
3:4
3:4
3:4
4:3
6:5
6:5
3:4
3:4
3:4
5:4
5:6
4:5
6:5
4:3
2:3
4:3

Diagnosis
Tumor
Tumor
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Tumor
Normal
Normal
Tumor
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal

score is based on the final pathology report per patient

Gleason Scorea
(4+5)9
(4+5)9
(4+5)9
(4+5)9
(4+5)9
(4+5)9
(4+5)9
(4+5)9
(4+5)9
(4+5)9
(4+5)9
(4+5)9
(4+5)9
(4+5)9
(4+5)9
(4+5)9
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
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Table 3.2 Samples for TS evaluation set
Patient #
1
1
2
2
2
3
3
3
4
4
4
4
5
6
6
6
7
7
7
8
8
8
8
9
9
9
10
11
11
11
12
13
13
13
13
14
14
14

Biopsy #
6
8
3
3
2
9
7
7
6
6
7
7
6
6
3
3
10
12
12
9
9
15
15
15
15
17
11
5
23
23
14
9
11
14
18
2
2
3

Sample # TS
4
1
1
1
1
3
2
2
1
1
5
5
5
1
2
2
5
2
2
4
4
3
3
4
4
5
4
3
3
3
4
5
2
3
3
5
5
5

Diagnosis
Tumor
Normal
Tumor
Normal
Normal
Normal
Normal
Normal
Normal
Tumor
Normal
Normal
Tumor
Tumor
Normal
Normal
Normal
Normal
Tumor
Normal
Tumor
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal

Gleason Scorea
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+5)9
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(4+3)7
(4+5)9
(4+5)9
(4+5)9
(4+3)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(4+3)7
(4+3)7
(4+3)7
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Table 3.2, Continued
Patient #
14
14
14
14
14
14
14
14
14
14
14
15
15
15
15
15
15
15
15
15
15
15
15
15
15
16
16
16
16
16
16
16
16
16
16
16
16
16

Biopsy #
4
4
5
6
8
8
10
10
12
12
14
2
3
3
8
8
10
10
11
12
13
14
14
15
15
7
7
10
11
11
12
12
14
14
15
15
16
16

Sample # TS
3
3
4
4
5
5
5
5
5
5
3
5
4
4
5
5
3
3
5
5
4
5
5
4
4
6
6
5
4
4
4
4
3
3
3
3
2
2

Diagnosis
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal

Gleason Scorea
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7
(4+3)7

74
Table 3.2, Continued
Patient #
17
17
17
17
17
17
17
17
17
17
17
17
17
17
17
17
17
17
17
17
17
17
18
18
18
18
18
18
18
18
18
18
18
18
aGleason

Biopsy #
1
1
2
4
4
5
5
6
6
7
7
8
8
9
9
10
10
12
13
13
15
15
3
4
7
7
10
10
11
11
12
13
16
16

Sample # TS
6
6
5
5
5
4
4
5
5
3
3
3
3
4
4
6
6
4
5
5
4
4
4
2
4
4
4
4
3
3
5
4
4
4

Diagnosis
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Tumor
Normal
Normal
Normal
Normal
Normal
Normal
Tumor
Normal
Normal
Normal
Normal

score is based on the final pathology report per patient

Gleason Scorea
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(3+4)7
(5+4)9
(5+4)9
(5+4)9
(5+4)9
(5+4)9
(5+4)9
(5+4)9
(5+4)9
(5+4)9
(5+4)9
(5+4)9
(5+4)9
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Table 3.3 PCA-LDA cross-validation results for DESI and TS targeted datasets
(A) DESI-MS CV prediction rates
Normal
98.7%
Tumor
96.2%
Average
97.5%
(B) DESI-MS CV confusion matrix
Species
Normal
Tumor
Normal
73
1
Tumor
1
25

(C) TS-MS CV prediction rates
Normal
96.1%
Tumor
95.8%
Average
96%
(D) TS-MS CV confusion matrix
Species
Normal
Tumor
Normal
73
3
Tumor
1
23
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Table 3.4 Stepwise-LDA validation results for TS targeted and non-targeted datasets
(A) TS-MS stepwise LDA on the
targeted dataset
Normal
100%

(C) TS-MS non-targeted prediction rates
Normal

96%

Tumor

100%

Tumor

89%

Average

100%

Average

92.5%

(B) TS-MS stepwise LDA targeted
confusion matrix
Species
Normal
Tumor

(D) TS-MS non-targeted confusion
matrix
Species
Normal
Tumor

Normal

74

0

Normal

97

4

Tumor

0

26

Tumor

1

8
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Figure 3-1 DESI-MS ion images displaying relative distributions of ions m/z 788, 885, 786,
835, 861, and 883. Ions correlating to prostate cancer based on PCA (i.e. m/z 786, 835,
861, and 883) have high relative abundances in the middle of the ion images unlike ions
with no correlation to disease state (i.e. m/z 788 and 885) which have high relative
abundances across the entire tissue section.
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Figure 3-2 (A) Average targeted DESI-MS of normal prostate tissue samples (N = 74). (B)
Average targeted DESI-MS of prostate cancer tissue samples (N = 26). (C) Prostate tissue
biopsy example with black dashed outlined region of cancerous tissue diagnosed by
histopathology, tissue section example was imaged by DESI-MS. (D) Average targeted
TS-MS of normal prostate tissue samples (N = 74). (E) Average targeted TS-MS of prostate
cancer tissue samples (N = 26). (F) Adjacent prostate tissue biopsy to the DESI example
analyzed by TS-MS, again the cancerous region diagnosed by histopathology is outlined
with dashed black line, the two missing regions from the biopsy correspond to locations of
TS-MS analysis.
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Figure 3-3 (A) DESI-MS PCA score plot, PC2 vs. PC3, displaying separation of prostate
cancer (red objects) and normal prostate tissue samples (dark green objects). (B) TS-MS
PCA score plot, PC3 vs. PC4, displaying separation of prostate cancer (red objects) and
normal prostate tissue samples (dark green objects).
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Figure 3-4 (A) DESI-MS PCA loading plot, PC2 vs. PC3, displaying ions which contribute
to the separation of prostate cancer and normal prostate tissue samples in the corresponding
PCA score plot. (B) TS-MS PCA loading plot, PC3 vs. PC4, displaying ions which
contribute to the separation of prostate cancer and normal prostate tissue samples in the
corresponding PCA score plot.
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Figure 3-5 (A) Canonical variable 1 vs. 2 score plot displaying separation of prostate cancer
(red objects) and normal tissue samples (dark green objects) for DESI-MS targeted dataset.
(B) Canonical variable 1 vs. 2 score plot displaying separation of prostate cancer (red
objects) and normal tissue samples (dark green objects) for TS-MS targeted dataset.

82

Figure 3-6 CCA correlation plot between DESI (X) and TS (Y) with the first 3 correlation
variables of 0.94, 0.76, and 0.68.
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Figure 3-7 (A) CCA loading plot displaying greatest canonical variable contribution from
the DESI principal components which correlate to biochemical information related to
healthy and diseased states. (B) CCA loading plot displaying greatest canonical variable
contribution from the TS principal components which correlate to biochemical information
related to healthy and diseased states.
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Figure 3-8 (A) TS-MS obtained in vitro from radical prostatectomy case 19, lipid pattern
suggests sampled area was obtained from a region of prostate cancer and this agrees with
gross pathology findings. (B) TS-MS obtained from a targeted prostate cancer sample from
the TS training set. Similarities, especially those related to lipids correlating to prostate
cancer based on statistical findings, can be seen between the in vitro spectrum and the
targeted spectrum.
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CHAPTER 4.
DESORPTION ELECTROSPRAY IONIZATION – MASS
SPECTROMETRY DIFFERENTIATION OF CANINE NON-HODGKIN’S
LYMPHOMA FROM NORMAL LYMPH NODE TISSUE USING SURGICAL
TISSUES AND FINE NEEDLE ASPIRATE SMEARS

4.1

Introduction

Non-Hodgkin’s lymphoma (NHL) is a large diverse group of cancers of
lymphocytes or white blood cells. NHL is the 7th most common human cancer in the U.S.
resulting in an estimated 20,000 deaths in 2014.1 Canine lymphoma is currently being
considered as a meaningful comparative model for human NHL, while important in its own
right.2,3 Some comparative modes, like canine lymphoma, closely mimic disease
characteristics such as rates of occurrence, subtype occurrence, disease progression, and
prognosis to that of the human disease characteristics. Diagnosis of NHL is acquired
through histopathological evaluation of the surgically removed suspect lymph node (whole
or in part). Histopathological diagnosis is based on morphological and cytological features,
such as morphological growth pattern, nuclear size and shape, and mitotic index.4,5 Fine
needle aspirate (FNA) biopsy is a less invasive alternative diagnosing method to surgical
resection of tissue. FNA is performed using a hypodermic needle that is inserted into a
suspicious lymph node to remove a small amount of cellular material. The cellular material
removed is simply expelled onto a microscope slide, and smeared to form a thin cellular
layer which then is evaluated using light microscopy following cytochemical or
immunocytochemical staining. Challenges with diagnosing using this method occur due to
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smaller sample size and lack of morphological information which can result in higher
rates of false negatives and inconclusive diagnoses.6 Aside from the advantages of being
a less invasive method, FNA procedures are also less expensive and less technically
demanding to perform.7,8 Thus, identifying methods to enhance the quality of diagnostic
information afforded by FNA would be worthwhile.
Desorption electrospray ionization – mass spectrometry (DESI-MS) has been
discussed in the previous Chapters as an ambient ionization technique that investigates the
chemical profiles of surfaces, including tissue, at native atmospheric conditions
(temperature, pressure, and humidity).9 As discussed previously, DESI-MS imaging has
been applied to studying lipid profiles of human brain10, kidney11, liver12, and prostate13
cancers as well as canine bladder14 cancer and others15,16 for potential use in surgical and
clinical settings. The DESI-MS data is used by multivariate statistic methods for pattern
recognition, such as principal component analysis (PCA) followed by supervised
classification techniques (like linear discriminant analysis, LDA), for visualization and
classification of differences between the samples and potentially complex relationships
(e.g. tumor subtype, grade, or cell concentration) within large datasets.
In this Chapter, canine lymphoma surgical tissue sections and FNA smears are
explored by DESI-MS for disease state and further subtype differentiation. DESI-MS
imaging of the surgical tissue sections allowed for direct correlation of lipid profiles to
specific disease state regions confirmed by histopathology. This initial work establishes a
relationship of indicative biochemical information to disease states with which to compare
lipid profiles obtained from FNA smears. FNA analyzed by ambient ionization - mass
spectrometry has previously neither been demonstrated to be of diagnostic use nor shown
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to yield similar information to that of the primary tissue from which it was obtained. The
characteristic lipid profiles obtained from surgically resected lymph nodes and FNAs are
certainly complementary, and potentially an alternative, to invasive procedures in
combination with histopathology and less reliable diagnosis in combination with cytology.
Comparison between previous data regarding the significant lipids in human NHL and this
canine study provide molecular support for a canine comparative model.

4.2

Experimental

4.2.1 Specimens
Specimens were provided by the College of Veterinary Medicine, Purdue
University. All NHL specimens were collected from pet dogs presented to the Purdue
University Veterinary Teaching Hospital (PUVTH) for medical treatment of their cancer.
At the time of presentation, fine needle aspirate samples were collected from an affected
lymph node in each dog using a 22 gauge hypodermic needle. FNA samples were expelled
onto glass slides, allowed to air dry, and then stored at -80oC until the time of DESI-MS
analysis. Immediately following FNA, all dogs with NHL underwent surgical resection of
the same affected peripheral lymph node. A portion of each resected tissue was fixed in
10% neutral buffered formalin and submitted for histopathologic confirmation of NHL.
The residual portion of each dog’s resected lymph node tissue was snap frozen in liquid
nitrogen, and the samples were stored at -80oC until the time of DESI-MS analysis. Lymph
node samples from healthy, purpose-bred research dogs served as normal controls. All
control animals had been humanely euthanatized as part of an academic laboratory course
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within the Purdue College of Veterinary Medicine Doctor of Veterinary Medicine degree
curriculum. Surgical lymph node tissue and FNA samples of peripheral lymph nodes were
collected immediately post-mortem from all control animals in identical fashion to that
described for pet dogs with NHL. All lymph nodes from control animals were confirmed
to be histologically normal following light microscopic review of H&E stained sections
from formalin-fixed tissues by a board-certified veterinary pathologist (JAR). All medical
and surgical procedures conducted on both control animals and pet dogs were approved by
the Purdue Animal Care and Use Committee. The number of canine specimens analyzed is
indicated in Table 4.1 by sample diagnosis and type (i.e. surgical tissue or FNA).

4.2.2 DESI-MS Analysis
Frozen surgical tissue specimens were cryosectioned at 15 μm thickness using a
Cryotome FSE (Thermo, Waltham, MA, USA) and thaw mounted on glass microscope
slides (Gold Seal Rite-On Microscope Slides, Thermo). Prior to analysis, the slides were
allowed to come to room temperature and briefly dried using an electronic desiccator
(VWR, Desi-Vac Container, Radnor, PA, USA) for approximately 10 minutes to remove
any frozen condensation resulting from storage. FNA smears were also dried for ~10
minutes prior to analysis, for the same reason, and analyzed under the same conditions.
Normal and tumor samples were randomized over multiple days of analysis, surgical tissue
sections and specimen matched FNA were analyzed on the same day. DESI-MS was
performed using a lab built prototype ionization source coupled to a linear ion trap mass
spectrometer (LTQ, Thermo). DESI-MS was carried out in the negative ion mode using
equal parts dimethylformamide (DMF) and acetonitrile (ACN), preserving tissue
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morphology and allowing subsequent histopathology to be performed on the analyzed
tissue section. DESI analysis was performed using the following major parameters:
automatic gain control (AGC) off, 5 kV spray voltage, 180 PSI N2(gas), incident spray angle
was 52˚, capillary temperature of 275°C, spray-to-surface distance ~2 mm, and spray-toMS inlet distance ~8 mm. Sample slides were analyzed by securing them to a moving stage.
The MS scan rate was coordinated with the moving stage speed in the “x” dimension (i.e.
rows), defining resolution (200 μm). Upon the completion of each row, the moving stage
was stepped vertically in 200 μm increments defining the “y” resolution.

4.2.3 Pathology
Histopathologic review, with tumor subtyping according to World Health
Organization criteria, was performed on formalin-fixed lymph node tissue sections as part
of routine clinical diagnosis. The clinical diagnosis was used for DESI-MS data correlation.
Samples thought to contain heterogeneous morphological features were evaluated post
DESI-MS analysis and annotated by histopathologic review of frozen tissue sections. There
were no cases in which histopathology review differed between frozen and formalin-fixed
tissue sections. The annotated regions were used to define areas associated with nonmalignant morphological features, unless otherwise noted.
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4.2.4 Data Analysis

4.2.4.1 DESI-MS Ion Images
Surgical tissue and FNA smear data acquired using XCalibur 2.0 (.raw) were
converted with an in-house program into files compatible with BioMap software
(http://www.maldi-msi.org). BioMap was used to generate 2D ion images (retaining spatial
relationships and displaying relative mass spectral abundance of particular mass-to-charge
ratios), select regions of interest (ROI) based on pathology, and export data for multivariate
analysis. An in-house MatLab (MathWorks, Inc., Natick, MA, USA) routine was used to
explore chemical features present in two dimensional DESI ion images. PCA was
performed upon each spatial pixel (and corresponding mass spectrum) and plotted using
an interactive brushing procedure. An interactive brushing procedure was performed,
connecting object grouping in PCA space to similarity in chemical information and spatial
location (i.e. pixels).17 Objects are manually selected from the score plot and visualized in
a 2D image - pixels associated with the selected region are colored coded. This allowed
heterogeneous samples to be manually investigated, correlating histopathology and
chemical composition.

4.2.4.2 Multivariate Analysis of Surgical Tissues
Multivariate analysis was performed using in-house MatLab routines. PCA was
used to explore DESI-MS data and visualize the grouping of samples resulting from
chemical similarity.18 The mass range was truncated (m/z 700-1000) for statistics, as it was
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empirically found to contain less analytical variability, providing more consistent and clear
separation with regards to disease state (i.e. normal vs. tumor). Two specimens were
excluded from statistics: one lymphoma sample (due to poor MS signal) and a metastatic
carcinoma. MS data were normalized by the total ion current (TIC) and column-centered
(i.e. mean-centered). LDA was performed for discriminant classification after
unsupervised data compression by PCA (i.e. PCA-LDA), as reported elsewhere.19 The first
8 principal components (PCs), accounting for ~90% of total data variation, were used.
Cross validation (CV) with 5 deletion groups was used to test the prediction ability in
classifying samples.

4.2.4.3 Multivariate Analysis of FNAs
Average DESI mass spectra obtained from FNA smears were compared with those
of surgical tissue via multivariate statistics. Direct comparison of FNA smear mass spectra
with a database built on mass spectra from surgical tissue sections was performed by
overlaying FNA samples onto the PCA score space (PC2 vs. PC5 score plot) defined by
the surgical tissue samples. The FNA smear data matrix (SNV normalized) was meancentered with the centroid (i.e. the row vector containing the mean values of each m/z
variable) of the surgical tissue data matrix (SNV normalized). Multiplication of the FNA
centered data with the loading matrix defined for the surgical tissue samples yielded a PCA
score matrix for the FNA samples. Surgical and FNA score values for PC2 and PC5 were
overlaid in the same score space. Further, FNA data were classified using a PCA-LDA
classification method developed with surgical tissue section data.
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4.3

Results and Discussion

4.3.1 DESI Imaging of Surgical Tissue
DESI-MS analysis of surgical tissue aims to explore and establish the lipid profiles
indicative of normal and NHL tissue and further NHL tumor subtypes. Negative mode
DESI mass spectra showed ionized fatty acids (e.g. oleic acid, m/z 281), fatty acid dimers,
and glycerophospholipids from m/z 700-1000 (e.g. PI(38:4), m/z 885). The major
glycerophospholipids (GPL) ions observed included: phosphatidylinositols (PI),
phosphatidylserines (PS), phosphatidylethanolamines (PE), and phosphatidylglycerols
(PG). The majority of lymphoma containing tissue sections displayed a conserved lipid
profile that contrasted normal tissue, and varied more slightly between B-cell and T-cell
subtypes.
Some differences in the chemical information within an analyzed tissue section
were noted for a few of the normal and tumor specimens. In all of these cases (with the
exception of cases with mixed disease states) the difference in chemical information
resulted from the presence of perinodal adipose tissue, as determined by post hoc
histopathology. Specimen 31 is illustrative, Figure 4-1B, a surgical tissue section
comprised primarily of a B-cell tumor with smaller regions of non-neoplastic, perinodal
adipose tissue. The lipid profile is homogenous throughout the tumor regions; however,
the small regions corresponding to perinodal adipose tissue (outlined) are show
significantly different lipid profiles and overall lower absolute signal intensity as seen in
each ion image (particularly m/z 281.5). The chemical difference of this region was further
explored using PCA and an interactive brushing procedure, see Figure 4-2. The PCA score
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plot, displaying each pixel from the DESI image, of specimen 31 indicated three groups
within the tissue section: B-cell lymphoma associated pixels (red selection), perinodal
adipose associated pixels (green selection), and background associated pixels (black). The
results of visual interpretation and PCA of the MS images correlated well with the
pathological assessment, considering the differences in spatial resolution of MS imaging
and histopathology. Perinodal adipose tissue was also detected in some of the normal
lymph node cases, for example specimen 42, as shown in Figure 4-1C. The difference in
the lipid profile was again evident between the two regions with GPL signal only abundant
in the lymph node parenchyma. The low GPL signal in adipose tissue is likely correlated
to adipocytes (i.e. fat cells), which typically have a large cytoplasmic volume to GPL
membrane surface area ratio. Adipocytes also contain greater levels of triglycerides and
cholesteryl esters which are not readily detected in the negative mode with the solvent
conditions chosen. However, detection of such compounds in positive ion mode from
biological material has been reported with the addition of silver nitrate to the solvent
reservoir.20,21

4.3.2 Data Analysis of DESI Evaluated Surgical Tissue
The lipid profile of surgical tissues was statistically explored (qualitatively and
quantitatively) for molecular-based differentiation of disease state (normal versus tumor)
and tumor subtype (i.e. B-cell lymphoma versus T-cell lymphoma). The average DESI
mass spectrum (from m/z 700-1000) of all normal lymph node, B-cell lymphoma, and Tcell lymphoma tissue sections, green, blue, and gold respectively, are displayed in Figure
4-3A-C. Overall, the lipid profiles of the three cases look distinctly different from each

94
other. The ratios of m/z 788.3 to 838.5 to 885.5 were found to differ between normal, Bcell, and T-cell samples. The average spectra obtained from lymphoma specimens
contained less abundant peaks that differed in abundance from normal samples including
m/z 747.4, 773.3, 786.4, 812.4, 883.5. The lipids that were altered in lymphoma and their
relative changes mirror those reported previously by Eberlin et al. in murine and human
specimens.22
The hierarchy of diagnosis starts with the differentiation of the disease state, normal
or tumor. PCA showed grouping of normal lymph node (green) and tumor (red) samples,
Figure 4-3D. Dispersion of the tumor samples in the PCA score plot, compared with the
normal samples, is indicative of greater chemical heterogeneity. NHL subtyping has two
major divisions, B-cell and T-cell, correlated to the lymphocyte immunophenotypes from
which the cancer originated. The dispersion of the lymphoma samples might be related to
the tumor subtype, Figure 4-3E, normal (green), B-cell lymphoma (blue), and T-cell
lymphoma (gold) samples. The PCA loading plot, displayed in Figure 4-3F, aided in
understanding which lipids from m/z 700-1000 contributed most to PC2 and PC6
computation (see Figure 4-4). Visual comparison of this information to the average spectra
of each class (i.e. normal, B-cell, or T-cell) supports the basis of the PCA separation.
Distinguishing NHL subtypes represents another level in the hierarchy of diagnosis and is
typical performed by a combination of standard histopathology and more extensive
immunohistopathology. Separation of B-cell and T-cell lymphoma is suggested in Figure
4-3E; however, upon removal of the normal samples from PCA, separation of B-cell and
T-cell tumor subtypes is more apparent (Figure 4-5). This example represents a potential
hierarchy of molecular diagnosis, similar to that of histopathology, where differentiation
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of disease state (i.e. tumor or normal) is first obtained based on an entire library of spectra
according to the disease and then more specific information may be investigated using a
smaller population of the library for better diagnosing (e.g. tumor subtype from the tumor
library). The ability to subtype tumors using DESI-MS has been previously demonstrated,
e.g. brain and kidney tumors.10,11 However, lymphoma subtyping has not been reported.
The quantitative performance of the PCA results from the DESI-MS data in
determining disease state and subsequently tumor subtype from surgical tissue sections was
performed using a discriminant classification model created using PCA-LDA. Crossvalidation was performed using five deletion groups resulting in an average prediction
classification rate of 96%, Table 4.2a, for disease state (i.e. normal versus tumor).
Differentiation of tumor subtype was also successful with an average predicted
classification rate of 96%, Table 4.3a. The predicted classification of T-cell lymphoma
(85.7%) was relatively poor in comparison to the other states (normal, 96% and B-cell
lymphoma, 100%), likely the result of a smaller sample size (n=7).

4.3.3 DESI Imaging of FNA
FNA smears, prepared using standard protocols, were analyzed without any
additional sample pre-treatment. It was assumed that aspiration and subsequent smearing,
was sufficiently homogenizing. Therefore, DESI imaging was performed on a small area
of the smear, representing a time reducing strategy for preliminary diagnosis. The MS data
obtained from FNA samples were very reminiscent of surgical tissue sections.
Representative specimen matched surgical tissue and FNA samples are displayed in Figure
4-6. The surgical tissue section of specimen 18 and the corresponding FNA smear
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possessed nearly identical lipid profiles, characteristic of B-cell lymphoma. Similarly,
specimen 38, appeared normal in both the surgical tissue section and the FNA smear, note
the characteristic ratio of ions m/z 788, m/z 838, and m/z 885.
FNA smears were nearly always chemically homogenous supporting the
assumption of sufficient homogenization, however changes in the total signal intensity
were common (Figure 4-7A). The presence of blood in some smears, smear visually red
in coloration, caused distinct changes in the lipid profile obtained. The presence of blood
contamination significantly increased one particular lipid, m/z 810, which corresponds to
PS(40:6) a major membrane constituent of erythrocytes.23 Minor blood contamination did
not seem to cause a significant change to the lipid profile. Two major variables in FNA
samples were found to affect total signal intensity: the quantity of cellular material
aspirated and the degree of dilution due to smearing. The effect of quantity is seen in Figure
4-7B in which the heterogeneity present in the ion image results from variable amount of
material – signal intensity is correlated with material quantity. The degree of smearing of
the aspirated sample or diluting of the cellular material is necessary for current cytology in
which isolated cells are desirable, while undesirable for chemical analysis by DESI-MS
where limits of detection may come into question, although single cell analysis has been
previously reported. Slight modification to current FNA smear protocols that compensate
for these effects is likely to increase MS reproducibility, data quality, and molecular
diagnosis capability.
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4.3.4 Data Analysis of DESI Evaluated FNA
The chemical information obtained from FNA smears by DESI imaging was
evaluated by multivariate statistics to determine diagnostic performance as well as to
explore how translatable the chemical information obtained from surgical tissue sections
is to FNA smears. Diagnostic performance was qualitatively explored by projecting FNA
samples onto the PCA score space of the matched surgical tissue samples, displayed in
Figure 4-8. The clinical information relevant to screening and preliminary diagnosis is the
identification of tumor. Visually, the separation and grouping of normal and tumor
samples, Figure 4-8A and 4-8B respectively, is mostly consistent with the matched surgical
tissue samples. Multiple regions were analyzed from a select number of tumor FNA
samples (specimen 8, 13, and 19) that appeared spatially heterogeneous, hence the 29
tumor points in Figure 4-8. The regional points from these specimens grouped tightly and
correctly in the tumor region, suggesting the appeared heterogeneity is simply due to total
signal heterogeneity. This supports previous discussion of mass spectral chemical
homogeneity and the need for slight modifications to the FNA smear protocol for DESIMS.
The quantitative diagnostic performance was evaluated by testing the FNA smear
data against the classification training set built from surgical tissue samples data. The PCALDA classification results are displayed in Table 4.4a. The overall predicted classification
rate of normal and tumor FNA samples was 87.5% with 4 false negative and 1 false
positive. Although classification results are slightly worse than that predicted in crossvalidation of the surgical tissue, the results support that the chemical information relevant
to disease state is equivalently detected in the surgical tissue and FNA by DESI-MS. FNA
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smears are known to be less reliable than surgical tissue samples evaluated by
histopathology and are neither adapted nor optimized for MS analysis.
As is the case with molecular diagnosis of NHL using surgical tissue by DESI-MS,
the alternative envisioned application of molecular diagnosis of NHL using FNA smears
would also include the ability of tumor subtyping. PCA cross-validation of surgical tissue
indicated the possibly for tumor subtyping (average predicted classification rate of 96%)
which is further explored using FNA smears. PCA-LDA was performed as above,
developing a classification training set using the surgical tissue samples for evaluation of
the FNA samples (predicting disease state). The overall average predicted classification
rate, displayed in Table 4.5a, was 76.2% with 2 false negatives, 1 false positive, and 1
tumor subtype misclassification. The overall prediction rate was greatly lowered by the
poor classification rate of the T-cell lymphoma subtype (50% correctly predicted
classification rate). This low classification rate is likely due to both the low number of
initial T-cell surgical tissue specimens used in training set (n=7 and surgical tissue CV rate
of 85.7%) and the even lower number of T-cell FNA samples (n=4) of which to be
evaluated against the training set. However, the B-cell FNA samples which had a much
larger surgical tissue training set (n=27) and FNA test set (n=27) had a predicted
classification rate of 93%. The results indicate that tumor subtyping is probable while only
conclusions concerning classes with sufficient sample numbers (normal and B-cell NHL)
can be drawn. It is expected that extension of this method to include a more diverse and
abundant population of samples will result in an overall higher predicted classification rate.
Overall, the primary goal of FNA analysis by DESI was demonstrated, rapid molecularbased differentiation of normal and tumor specimens, which has promise as a
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complimentary method to cytology and could significantly enhancement the rapid
diagnosis of lymphoma.

4.4

Conclusions

Differences in the lipid profile, acquired by DESI-MS, allowed differentiation of
normal lymph node and NHL tumors from surgical tissue and FNA smears. Normal lymph
node tissue was chemically homogenous while differences in absolute signal were noted
between normal lymph node anatomy, e.g. medulla and cortex. Tumor samples were
generally homogenous, particularly B-cell NHL samples matching known tumor growth.
Some normal lymph node and tumor samples contained perinodal adipose which typically
had an absence of signal, likely due to the conditions of the experiment. Multivariate
statistics allowed for qualitative and quantitative differentiation of normal and tumor
surgical tissue samples, the latter yielding a predicted classification rate of 96%. Further,
subtyping of the surgical NHL tumor tissues was possible with an equal predicted
classification rate.
FNA smears, previously unexplored for diagnosis using ambient ionization – mass
spectrometry, provided the same chemical information relevant to disease state
differentiation as the surgical tissues. Multivariate analysis of the FNA smears yielded an
average classification rate of 87.5% for normal vs. tumor and 76.2% for NHL subtypes
when using the classification method built from the surgical tissue data. DESI-MS signal
was dependent on the smear composition (e.g. blood contamination), aspirated material
quantity, and the dilution factor of the material by smearing. Changes in the FNA protocol
to tailor for MS analysis is likely to improve results.
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DESI-MS imaging of surgical tissues provided a means of exploring and
establishing the lipid profiles indicative of normal lymph node and NHL subtypes. The
process of FNA and smearing loses histological information such as the tissues
morphology, however the biochemical information related to those changes is still easily
detected by DESI-MS. Tumor subtype prevalence, clinical behavior, and chemical changes
in GPL all emulate that of human NHL, which supports the development and use of canine
comparative models. The methodology outlined in this Chapter is novel and applicable to
dogs while translatable to human cases as well.
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Table 4.1 Canine NHL Surgical Tissue and FNA Specimen Information

Specimen #

Histopathology Diagnosis
(Formalin-fixed)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45

T-zone lymphoma
Diffuse large B-cell lymphoma
Diffuse large B-cell lymphoma
Peripheral T-cell lymphoma
T-zone lymphoma
B-cell lymphoma, tonsil
T-cell lymphoma
Diffuse large B-cell lymphoma
Diffuse large B-cell lymphoma
Diffuse large B-cell lymphoma
Diffuse large B-cell lymphoma
Metastatic carcinoma
Diffuse large B-cell lymphoma
T-zone lymphoma
Diffuse large B-cell lymphoma
Diffuse large B-cell lymphoma
Diffuse large B-cell lymphoma
Diffuse large B-cell lymphoma
Diffuse large B-cell lymphoma
Diffuse B-cell lymphoma
Diffuse large B-cell lymphoma
Diffuse large B-cell lymphoma
Diffuse large B-cell lymphoma
Diffuse large B-cell lymphoma
Peripheral T-cell lymphoma
Diffuse large B-cell lymphoma
Peripheral T-cell lymphoma
Diffuse large B-cell lymphoma
Diffuse large B-cell lymphoma
Diffuse large B-cell lymphoma
Diffuse large B-cell lymphoma
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal

Sample Included in
Statistics
Surgical Tissue
FNA
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x

Comments

5 FNA ROIs

x

Excluded
4 FNA ROIs

x
x
x
x
x

4 FNA ROIs

x
Excluded (MS signal)

x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x

x
x
x
x
x

x

x

x

2 FNA ROIs

105
Table 4.1, Continued

Specimen #
46
47
48
49
50
51
52
53

Histopathology Diagnosis
(Formalin-fixed)
Normal
Normal
Normal
Normal
Normal
Normal
Normal
Normal

Sample Included in
Statistics
Surgical Tissue
FNA
x
x
x
x
x
x
x
x
x
x
x

Comments
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Table 4.2 Surgical Tissue Classification Rate and Confusion Matrix Information for Tumor
and Normal Disease States
(a) Surgical Tissue Classification Rates
Normal
91.7%
Tumor
100%
Average
96%
(b) Surgical Tissue Confusion Matrix
Species
Normal
Tumor

Normal

Tumor

22
0

2
27
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Table 4.3 Surgical Tissue Classification Rate and Confusion Matrix Information for Tumor
Subtype and Normal Disease States
(a) Surgical Tissue Classification Rates
Normal
95.6%
B-cell
100%
T-cell
85.7%
Average
96%
(b) Surgical Tissue Confusion Matrix
Species
Normal
B-cell
T-cell

Normal

B-cell

T-cell

22
0
0

0
27
1

1
0
6
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Table 4.4 FNA Classification Rate and Confusion Matrix Information for Tumor and
Normal Disease States
(a) FNA Classification Rates
Normal
86%
Tumor
88%
Average
87%
(b) FNA Confusion Matrix
Species
Normal
Tumor

Normal

Tumor

6
4

1
28
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Table 4.5 FNA Classification Rate and Confusion Matrix Information for Tumor Subtype
and Normal Disease States
(a) FNA Classification Rates
Normal
86%
B-cell
93%
T-cell
50%
Average
76.3%
(b) FNA Confusion Matrix
Species
Normal
B-cell
T-cell

Normal

B-cell

T-cell

6
1
1

0
26
1

1
0
2
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Figure 4-1 Negative mode DESI-MS ion images displaying the distribution of ions m/z
281.5, 747.5, 788.4, 838.5, and 885.6 and the corresponding H&E stain for (A) a B-cell
lymphoma sample (Specimen 18) in regards to chemical and spatial homogeneity, (B) a Bcell lymphoma sample (Specimen 31), containing small regions of perinodal adipose
(outlined), and (C) an illustrative normal sample (Specimen 42) displaying a large region
of perinodal adipose (outlined) which was chemically different than that of the normal
lymph node tissue.
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Figure 4-2 (Left) H&E stain of specimen 31 with annotated non-neoplastic regions in
green. (Middle) DESI-MS pixel image with each pixel of the false color indicating
similarities in their chemical profile. (Right) PCA score plot of all pixels (i.e. MS) within
the DESI-MS pixel image with the grouping selected related to the false color represented
in each selection (all pixels not selected represent the black color pixels in the DESI image).
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Figure 4-3 Average negative ion mode DESI mass spectrum of surgical tissue for (A)
normal lymph node (n=22), (B) B-cell lymphoma (n=27), and (C) T-cell lymphoma (n=7).
(D) PCA score plot of normal (green) and NHL (red) samples. (E) PCA score plot of
normal (green), B-cell lymphoma (blue), and T-cell lymphoma (gold) samples. (F) PCA
loading plot corresponding to score plots in D and E.
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Figure 4-4 Loading plots for PC2 (left) and PC6 (right) with significant ions annotated by
mass-to-charge.
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Figure 4-5 (Left) PCA score plot for B-cell and T-cell lymphoma, gold and blue
respectively and (Right) corresponding PCA loading plot.
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Figure 4-6 Negative ion mode DESI-MS of (A) B-cell lymphoma (Specimen 18) obtained
from a surgical tissue section and (B) its matched FNA. Negative ion mode DESI-MS of
(A) normal lymph node tissue (Specimen 38) obtained from a surgical tissue section and
(B) its matched FNA.
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Figure 4-7 Negative mode DESI ion images corresponding to m/z 747, 788, 812, 838, and
885 of FNA smears corresponding to normal lymph node (top) and B-cell lymphoma
(bottom).
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Figure 4-8 (A) PCA of FNA normal lymph node samples (black diamonds) overlaid upon
score plot from the classification of surgical tissue, normal surgical tissue samples (green
circles) and NHL surgical tissue samples (red circles). (B) PCA overlay of FNA NHL
samples (black diamonds) on the same surgical tissue score plot described above.
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CHAPTER 5.
DIFFERENTIATION OF CLEAR CELL, PAPILLARY, AND
CHROMOPHOBE RENAL CELL CARCINOMA SUBTYPES BY DESORPTION
ELECTROSPRAY IONIZATION – MASS SPECTROMETRY

5.1

Introduction

Renal cell carcinoma (RCC) is the most common form of kidney cancer in adults.
This type of cancer forms in the lining of nephrons, the very small tubes in the kidney that
filter blood and transport waste to the urine. Kidney cancer is the 8th most common form
of cancer in the U.S. with an estimate of 64,000 new cases and 14,000 deaths in 2014.1
RCC is not a single disease, but a collection of different types of tumors, the most common
are clear cell, papillary, and chromophobe which represent about 70-80%, 10-15%, and 35% of all RCC cases respectively. Other rare types of RCC include collecting duct and
medullary, however collectively they only represent less than 1% of all RCC cases. Each
subtype of RCC is derived from various parts of the nephron and possess distinct genetic
characteristics, histological features, and clinical phenotypes.2 Prognosis varies depending
on stage and grade of each RCC subtype, but 5-year survival rates on average are about
70% for clear cell, 80% for papillary, and 85% for chromophobe.3 Treatment for RCC
includes surgery, radiation therapy, chemotherapy, immunotherapy, and targeted
therapy.1,2 However, RCC is highly resistant to traditional chemotherapy and radiation
therapy, and few patients benefit from immunotherapy as well.4,5 Over the past decade
discoveries in different RCC tumor growth pathways have led to successful treatment of

119
different RCC tumors using targeted treatments.6 Thus, accurate RCC diagnosis and
subtyping is important not only for prognostic value, but also for the prediction of targeted
therapeutic response.
As discussed in Chapters 1 through 4, DESI-MS imaging is an ambient ionization
technique that measures the lipid profiles, specifically glycerophospholipid profiles, in
tissues which is directly correlated to disease states when combined with histopathological
evaluations.7,8 After disease state correlation, DESI-MS data is used by multivariate
statistic methods (e.g. PCA or LDA) to create MS libraries which can be used for pattern
recognition to classify samples based on disease (e.g. tumor or normal) and potentially
complex relationships (e.g. tumor subtype, grade, or cell concentration). DESI-MS
imaging has been previously applied to analyze lipid profiles in several canine and human
cancers with successful differentiation of tumor and normal tissue in all cases.8-13 One of
the previously analyzed human cancers was RCC14, however only two subtypes were
investigated and sample numbers were limited for both. Further, the classification results
for tumor versus normal were obtained separately for specimen of each subtype and then
subtype classification results were obtained using all specimen.
In this Chapter, analysis of RCC subtypes clear cell, papillary, and chromophobe,
which represent about 99% of all diagnosed RCC cases, by DESI-MS imaging is discussed.
The biochemical information obtained by DESI is explored for differentiation of tumor and
normal tissue and further tumor subtypes. The goal of this work is to create a
comprehensive MS library to be used for classification of surgical tissue obtained from
partial and radical nephrectomy surgeries.
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5.2

Experimental

5.2.1 Study Protocols
All tissue specimens were handled in accordance with approved institutional review
board (IRB) protocols at Indiana University School of Medicine and Purdue University.
Paired normal and tumor specimens for clear cell (n=20), papillary (n=20), and
chromophobe (n=15) RCC subtypes were obtained from IUSM tissue procurement. Tissue
were cryosectioned at 15 μm thicknesses and each matched pair was thaw mounted to a
single glass microscope slide (10 replicate slides were made for each pair). One
chromophobe specimen contained all adipose fat and could not be sectioned for MS
analysis. Sections were stored at −80 °C prior to MS analysis. Tissue sections were allowed
to come to room temperature and then dried under nitrogen for approximately 15 minutes
in a desiccator prior to analysis. The same slide analyzed by DESI-MS imaging was H&E
stained and examined by an expert pathologist to identify from tissue morphology the
presence/absence of RCC and tumor subtype.

5.2.2 DESI-MS Imaging
DESI was performed using a laboratory-built ion source, similar to the commercial
2D source from Prosolia, Inc. (Indianapolis, IN, USA) and coupled to a linear ion trap mass
spectrometer (LTQ) controlled by XCalibur 2.0 software (ThermoFisher Scientific,
Waltham, MA). DESI-MS was carried out in the negative ionization mode with the
automatic gain control (AGC) inactivated. The spray solvent used for DESI-MS was
dimethylformamide (DMF)–acetonitrile (ACN), a morphologically compatible solvent, at
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a 1:1 ratio (v/v), both solvents were purchased from Mallinckrodt Baker Inc. (Phillipsburg,
NJ), and delivered at 1.0 μL min−1 flow rate using the instrument syringe pump. The DESI
source parameters were: capillary temperature 275 °C, voltage applied to the stainless steel
needle syringe 5 kV, capillary voltage −25 V, tube lens voltage −115 V, capillary incident
angle 54°, spray to surface distance 3 mm, sample to inlet distance 5 mm, and nitrogen gas
at 180 PSI. The tissue sections were analyzed using a moving stage with a lateral scan rate
coordinated to the MS scan rate to produce a mass spectrum every 200 μm across each
horizontal row. Horizontal rows were separated by a 200 μm vertical step, thus creating
200 μm x 200 μm pixels within each image. Full scan mass spectra were acquired in
negative ion mode in the mass range m/z 200–1000. For statistical analysis of the evaluation
dataset, a reduced mass range of 700–1000 was used, limiting the biochemical information
to complex glycerophospholipids.

5.2.3 Data Analysis

5.2.3.1 DESI-MS Ion Images
DESI ion images were prepared by the same method as described in Chapter 4.
Briefly, data acquired using XCalibur 2.0 (.raw) were converted with an in-house program
into files compatible with BioMap software (http://www.maldi-msi.org). BioMap was used
to generate 2D ion images (retaining spatial relationships and displaying relative mass
spectral abundance of particular mass-to-charge ratios) and select regions of interest (ROI)
based on pathology. The data were then imported into Matlab.
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5.2.3.2 Principal Component Analysis
Multivariate analysis was performed using in-house MatLab routines. PCA was
used to explore DESI-MS data and visualize the grouping of samples resulting from
chemical similarity.15 Specimens excluded from statistics included two normal and one
papillary. Two tumor tissue sections had subsections of normal tissue and where separated
into two areas for statistics. One normal tissue section had a subsection of normal with a
different spectral pattern, this tissue section was split into two separate ROIs for statistics.
One tumor tissue section had a subsection of tumor with a different spectral patter, this
tissue section was split into two separate ROIs for statistics. MS data were normalized by
standard normal variate (SMV) transform and column-centered (i.e. mean-centered). LDA
was performed for discriminant classification after unsupervised data compression by PCA
(i.e. PCA-LDA), as reported elsewhere.16 The first 8 principal components (PCs),
accounting for ~90% of total data variation, were used. Model validation (i.e. evaluation
of the predictive ability of the model) was performed by means of cross validation (CV).
For this study, five cross-validation deletion groups were selected, meaning that all the
samples were divided five times systematically in a training set (objects used for building
the classification model) and a test set (remaining objects used to evaluate the predictive
ability of the model), with all the samples being in the test set only once.
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5.3

Results and Discussion

5.3.1 DESI Imaging and Lipid Patterns
RCC is not a single disease, but a collection of different tumor types, most
commonly clear cell, papillary, and chromophobe. Histopathological diagnosis of RCC is
based on morphological and cytological features, such as morphological growth pattern
and nuclear size and shape.2 Along with these features, RCC subtyping can be supported
by immunohistochemistry to map the expression of proteins related to a specific subtype
(e.g. expression of α-metylacil-CoA racemase (AMACR) for papillary RCC or c-kit
expression for chromophobe RCC).17 Discussion in this Chapter aims to explore and
establish a relationship between the lipid profiles obtained using DESI-MS and the tissues
disease state (i.e. RCC or normal) and further RCC tumor subtypes.
Negative ion mode DESI-MS showed ionized fatty acids from m/z 200-350 (e.g.
oleic acid, m/z 281), fatty acid dimers from m/z 400-700 (e.g. oleic acid + oleic acid, m/z
563), and glycerophospholipids (GPL) from m/z 700-1000 (e.g. PI(38:4), m/z 885). The
lipid constituents used to investigate disease state were primarily GPLs (m/z 700-1000) as
they were empirically found to contain less analytical variability, providing more
consistent and clear distinction with regards to disease state. The major GPL ions observed
included

were

phosphatidylinositols

(PI),

phosphatidylserines

(PS),

phosphatidylethanolamines (PE), and phosphatidylglycerols (PG). These lipids can be
observed in the average normal, clear cell, papillary, and chromophobe mass spectrum in
Figure 5-1 A, B, C, and D respectively. Visually, the differences between lipid profiles of
normal and tumor can be very clear (i.e. normal vs. clear cell and papillary) or very subtle
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(i.e. normal vs. chromphobe). One of the clear differences observed is between the lipid
ratio of ions m/z 794 and 885 where in the normal lipid profile m/z 794 has almost an
identical peak height to m/z 885, however in clear cell and papillary m/z 794 has about a
third of the peak height of m/z 885. This difference is not as readily observed between
normal and chromphobe, although chromophobe seems to have less abundance of m/z 794
than normal, a better visualization difference between normal and chromophobe are the
ratios of m/z 723, 747, and 773 where m/z 723 and 747 are almost identical in peak height
and double that of m/z 773 in normal, but in chromophobe m/z 773 is almost double m/z
747 in peak height as is the same with m/z 747 to m/z 723. Some of these distinctions are
clear between the average spectra of specific disease states, however visual interpretation
of ~100 unique data points would be difficult to address. Therefore, multivariate statistical
analysis is needed to efficiently explore the chemical information contained in the mass
spectra.

5.3.2 Classification of RCC, Tumor Subtypes, and Normal Tissue using Lipid Profiles
Qualitative and quantitative statistical analysis of the lipid profiles obtained from
tissue was explored for molecular-based differentiation of disease state (i.e. normal and
RCC) and tumor subtype (i.e. clear cell, papillary, and chromophobe). Qualitative analysis
was performed by principal component analysis, an unsupervised statistical tool, to
produce 2-dimensional score plots displaying the lowest-order principal components (PCs)
for which separation between disease state and subtype was visually apparent.
Corresponding loading plots were also produced to display the ions which contribute the
most to each PC. Shown in Figure 5-2 A and B is the score and loading plot, respectively,
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related to RCC (red objects) and normal (dark green objects) separation and shown in
Figure 5-3 A and B is the score and loading plot related to tumor subtype (red objects –
clear cell, yellow objects – papillary, and orange objects – chromophobe) and normal (dark
green objects) separation. Although some separation is observed in the 2-dimensional plots,
PCA is multidimensional method and separation can occur in many of them.
A discriminant classification model created by PCA-LDA was used to determine
the quantitative performance of the PCA results (i.e. tumor vs. normal separation and tumor
subtype vs. normal separation) from the DESI-MS data. The first eight PCs were which
correlated to ~90% of the total variance of the dataset (~10% of total variance consists of
noise). Cross-validation was performed using five deletion groups resulting in an average
prediction classification rate of 92%, Table 5.1a, for disease state (i.e. normal versus
tumor). Classification of tumor subtype was also performed using the same method
described above with an average predicted classification rate of 85%, Table 5.2a. The
predicted classification of papillary RCC (73.3%) was relatively poor in comparison to the
other states (normal - 90.7%, clear cell – 80.1%, and chromophobe – 80%), likely the result
of convolution within the PCs, specifically, convolution with clear cell RCC. Clear cell
RCC is known to have much higher lipid content including cholesteryl esters18 (CEs) which
are readily observed in the positive ion mode when silver is added to the DESI solvent
spray.19,20 It is hypothesized that detection of CEs and similar lipids in the positive mode
using silver adduct experiments may help the separation of papillary and clear cell
subtypes, however this is outside of the scope of this Chapter.
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5.4

Conclusions

DESI-MS imaging was used to obtain lipid profiles from normal kidney and clear
cell, papillary, and chromophobe RCC subtypes. PCA-LDA was used to build discriminant
classification models to quantitatively asses PCA separation of disease states (i.e. tumor
vs. normal) and tumor subtypes (i.e. clear cell, papillary, and chromophobe vs. normal).
The average prediction rate for disease state classification was 92%. Further classification
of RCC subtype produced an average prediction rate of 85%. The 92% prediction rate for
tumor and normal discussed in this Chapter was similar to the average of the individual
classification rates (i.e. classification of tumor and normal was performed separately for
clear cell and papillary) reported in previous work, 92.2% for clear cell vs. normal and
85.7% for papillary vs. normal or an average prediction rate of 89%. The previous work
also reported classification of clear cell and papillary subtypes with an average prediction
rate of 76.3%, this rate is much lower than the average prediction rate of 85% for clear cell,
papillary, and chromophobe discussed in this Chapter. It is thought that the dramatic
increase in RCC subtype prediction rate is related to the increase in sample size from the
previous work to this work. Overall, the goal of building a classification model for disease
state and subtype differentiation for RCC was successful. Future work includes continuing
to increase sample size, and validating the classification model against surgical tissue of
unknown disease states.
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Table 5.1 Classification Rate and Confusion Matrix Information for Tumor and Normal
Disease States
(a) Kidney Classification Rates
Normal
89.1%
Tumor
95.6%
Average
92.3%
(b) Confusion Matrix
Species
Normal
Tumor

Normal

Tumor

49
2

6
43
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Table 5.2 Classification Rate and Confusion Matrix Information for Tumor Subtype and
Normal Disease States
(a) Tissue Classification Rates
Normal
Clear cell
Papillary
Chromophobe
Average

90.7%
81.3%
73.3%
80%
85%

(b) Confusion Matrix
Species
Normal
Clear cell
Papillary
Chromophobe

Normal

Clear cell

Papillary

Chromophobe

49
2
0
0

3
13
3
2

2
1
11
1

0
0
1
12
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Figure 5-1 Average negative ion mode mass spectrum for A) normal kidney tissue, B) clear
cell RCC, C) papillary RCC, and D) chromophobe RCC.
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Figure 5-2 A) PCA score plot of normal (dark green objects) and RCC (red objects)
samples and B) corresponding PCA loading plot of ions (lipids) which contribute to the
PCs.
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Figure 5-3 A) PCA score plot of normal (dark green objects), clear cell RCC (red objects),
papillary RCC (yellow objects), and chromophobe RCC (orange objects) samples and B)
corresponding PCA loading plot of ions (lipids) which contribute to the PCs.
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quantitation. Chemical derivatization is performed simultaneously with ionization.

Introduction
Ambient ionization produces ions outside the mass spectrometer from samples in their native state.1,2 Desorption electrospray ionization (DESI)3 was reported in 2004, and since then
more than forty ambient ionization methods have been
described.4–6 In some experiments such as DESI a single agent
(charged droplet impact) is used to desorb the analyte and to
eﬀect its ionization. In others, two separate agents are used to
perform the key operations of desorption and ionization: for
example, desorption can be achieved using a laser, plasma or
droplet and ionization can take the form of electrospray ionization, atmospheric pressure chemical ionization or laser
ionization. One of the main characteristics of ambient ionization is the speed of analysis – it requires a few seconds for the
entire process of sampling, ionization and recording of mass
spectra. This feature is the result of eliminating or greatly
relaxing sample pre-treatment, including avoiding separation
techniques prior to mass spectrometry. Ambient ionization
mass spectrometry displays wide applicability combined with
high sensitivity and the high molecular specicity characteristic
of mass spectrometry.7,8 Ambient methods based upon spray
ionization include DESI,3 nanospray desorption electrospray
ionization (nanoDESI),9 liquid microjunction surface-sampling
probe (LMJ-SSP),10 probe electrospray ionization (PESI),11 and
others. In each case solvent and high voltage are used to
generate the strong electric eld needed to produce charged
secondary droplets which leave the substrate carrying dissolved
analyte into the mass spectrometer. The emitted charged
droplets undergo coulombic ssion when suﬃcient surface
charge is accumulated as a result of solvent evaporation,
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eventually yielding analyte ions by mechanisms that parallel
those in electrospray ionization.
A family of methods exist which rely on spray based ionization from substrates:12 these methods include paper spray
(PS),13 PESI,14 and leaf spray (LS).15 Substrate spray methods
generate ions from sharp tips, naturally present or created,
and require a minute amount of sample. PESI, an early
example of ambient probe based ionization source, allowed
the analysis of liquid samples in situ. PESI utilizes smooth
metallic objects with sharp tips (e.g. acupuncture needles) to
transfer aliquots of sample solution for MS analysis and has
been applied by Hiroaka et al. to tissue analysis in cancer
diagnostics,16,17 protein analysis, and agrochemical analysis.18
Metallic probes such as those used in PESI provide a nonporous surface primarily serving as a means of analyte transport and application of high voltage. Organic materials (paper,
wood, and plant parts) have been used in substrate-based
electrospray sources. Substrates based on organic materials are
not only capable of generating ions but also provide a varying
ability for selective absorption of components of a mixture.
Mass spectra were recorded from wooden toothpicks by Yao
and colleagues19 who detected pharmaceuticals in applied
homogenous solution, and similarly by Chen et al. using
bamboo nibs, similar to those used in calligraphy.20 Analysis of
powders, sampled from locations otherwise diﬃcult to access
was achieved using moistened wooden toothpicks.21 PS is
similarly capable of in situ sampling with the detection of
analytes by wiping as in the detection of agrochemicals on the
surface of an orange.22
Touch spray (TS) ionization falls into this family of substrate
spray methods, using a probe (e.g. needle) to sample material
and solvent and an electrical potential to desorb analyte and
transfer it in ionic form into a mass spectrometer. TS allows in
situ sampling of materials from which ions are generated once
solvent (as needed) and a potential are applied. It is closely
related to the metallic probe substrate techniques such as PESI
and organic substrate techniques such as PS, and characterised
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by the ability to sample and absorb materials such as solid
powers, trace amounts of solids on surfaces, solutions, and
heterogeneous matrices (e.g. tissue) onto a probe. Absorbed
material can be transported from the point of origin to the MS
in two stages, rst by physical transfer of a small sample and
then by transfer of dissolved analytes in the sprayed droplets.
TS, as with other spray-based ambient ionization methods,
allows nearly simultaneous chemical derivatization and ionization, generating derivatives that can increase signal and
enhance qualitative identication. This publication describes
the methodology of TS and explores applications, with
emphasis on in situ analysis via illustrative examples.

Results and discussion
Touch spray ionization
Touch spray ionization is aimed specically at in situ analysis of
complex samples. Analytes are transferred from a particular
location in the sample using a roughed probe. Subsequently,
spray ionization (see ESI Fig. 1†) transfers the ionized analyte to
the mass spectrometer for analysis. The TS method incorporates a manual method of collecting a MS sample: sampling is
remote to the mass spectrometer and aer manual transfer
onto a probe, MS is performed directly from the sampling
device. It is not necessary to use a specic probe material or that
it have a particular physical form: the transfer of a minute
amount of material for MS analysis can be achieved by
touching, scratching, dipping, swiping, or otherwise attaching
sample material. The probe is then aligned with the mass
spectrometer, high voltage is applied, solvent is added, and
mass spectra are recorded. In these experiments the touch spray
probe was aligned with the atmospheric inlet (0.5–20 mm away)
and an appropriate voltage (3.0–5.0 kV) was applied to generate
a stable electrospray signal without a corona discharge. Solvent
was either applied manually via pipette (0.1–2 mL, which
provided mass spectral signals lasting only a few seconds) or
continuously via a syringe pump (yielding continuous signal
until analyte exhaustion, typically >1 min).
One suitable probe is a teasing needle (Fig. 1); these are
metallic, possess a sharp tip, and are roughened. The metallic
and roughened features appear to be benecial when sampling
and transferring material, such as biological tissue. The
crevasses in the roughened surface hold material during sample
transfer and analysis, facilitating analyte extraction. In addition, in the case of teasing needles, the angled feature was
found to increase reliability, as it accommodated solvent
application and was observed to promote solvent ow.
Complete wetting of the probe's surface improved extraction of
analytes and emission of solvent microdroplets, a feature which
was not observed in all probes evaluated.
Touch spray is user-guided, placing limits on the rate and
reproducibility of sampling. It is therefore semi-quantitative
with performance dependent on user experience. However, it
allows ready assessment of the presence or absence of analytes
in situ, information that is critical for applications in elds such
as forensics and quality control while also providing the ability

This journal is © The Royal Society of Chemistry 2014

Sampling of (A) solids and (B) liquids by touch spray ionization
using an angled teasing needle. (C) Application of high voltage and
solvent at the mass spectrometer causes release of analyte-containing
charged droplets.

Fig. 1

to monitor relative changes in ion abundances in applications
such as cancer diagnostics.
Detection of lipids from biological tissue
The lipid composition of mouse brain tissue has been extensively studied using ambient ionization mass spectrometry (e.g.
DESI)23 and therefore constitutes a biological standard by which
to qualitatively measure the performance of touch spray ionization. A minute amount of cellular and extracellular material
can be transferred to a touch spray probe using light abrasive
force on the biological material. For the sake of demonstration,
mouse brain tissue sections were sampled in this manner
removing material in a circle (diameter <1 mm). Touch spray
mass spectra displayed in Fig. 2 are similar to those acquired
with DESI, ESI Fig. 2,† in the negative ion mode is dominated by
signals due to fatty acids (m/z < 300), fatty acid dimers (m/z 300–
700), and glycerophospholipids (m/z 700–1000). The relative
abundances of m/z 888.5 (main constituent from previous
studies, sulfatide 24 : 1), 788.5 (phosphatidylserine 36 : 1),
834.5 (phosphatidylserine 40 : 6), and 885.5 (phosphatidylinositol 38 : 4) were used to qualitatively assess neural composition
(white and grey matter) as shown in Fig. 2. The transverse plane
of mouse brain possesses le-right hemisphere symmetry,
visible in the various staining features (e.g. cerebellum and
corpus callosum). Touch spray was performed at six positions
(Fig. 2) annotated upon the H&E stain. The touch spray mass
spectra from the mouse olfactory bulb (Fig. 2, point 1) displayed
unique ions detected at m/z 806.5 (PS 38 : 6) and 909.5 (PI 40 : 6)
corresponding to parallel ndings using DESI.23 Similarly, the
mass spectra recorded from point 2 indicated a high percentage
of white matter, corresponding to the corpus callosum. The
spectra recorded at point 5 show a high percentage of gray
matter (periaqueductal gray and/or cerebellum). At other points
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Fig. 2 (Upper left) H&E stain of a transverse mouse brain section after repeated sampling, annotated, by TS-MS (lower left) sampling point 1,
corresponding to the olfactory bulb which contained unique lipids detected at m/z 806.3 and 909.4 (right) TS-MS from annotated sampling
points displaying various levels of white and gray matter.

a mixture of gray and white matter was observed with point 3
corresponding to the thalamus, point 4 to periaqueductal gray
with white matter potentially from the posterior commissure,
and point 6 primarily white matter from the granular layer of
the cerebellum with some gray matter.
The reproducibility of touch spray was assessed using
coronal mouse brain sections. These sections are comprised of
either grey or white matter each possessing diﬀerent glycerophospholipids, reected in the spectra, and whose distribution is symmetrical between right and le hemispheres. Touch
spray was performed at six equally spaced points across one
coronal section (ESI Fig. 3†). Mass spectra were reproducible in
terms of the prominent glycerophospholipids ions seen and
also in terms of their approximate relative intensities. They were
similar between points of related neural composition; for
example, A and F indicated grey matter which produces patterns
including a base peak at m/z 834.5 and major peaks at m/z 788.5
and 885.5 whereas B and E displayed an ion m/z 888.5 with a
higher ratio of m/z 888.5 to 834.5 than m/z 788.5 or 885.5 to
834.5 indicating the presence of white matter.

cancer to assess malignant and non-malignant states. Prostate
cancer tissue from radical prostatectomy specimens was evaluated with TS using DESI imaging to validate the TS data.
Samples were collected using a disposable biopsy gun and
sectioned to allow evaluation by histopathology in serial
sections (<50 mm).
DESI and TS spectra acquired from a region of malignant
prostate cancer, determined by histopathology, are presented in
Fig. 3A and B, respectively. The H&E stained biopsy section
shown in Fig. 3C is a sample analyzed by DESI-MS with the
cancerous region outlined. TS-MS was performed on the

Ex vivo detection of malignant prostate cancer
The ability to discriminate prostate malignancy from nonmalignant states is vital for improving the care of patients, and
could be furthered by advances in molecular-based diagnostics.
DESI-MS can be used to distinguish cancer from normal tissue
in human brain tumors and to classify tumor subtypes, grades,
and tumor cell concentrations.24 TS is being applied to prostate

2716 | Analyst, 2014, 139, 2714–2720

Fig. 3 (A) DESI-MS and (B) TS-MS of region outlined in (C) corresponding to prostate malignancy as determined by histopathological
evaluation.
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adjacent section. The phospholipid region (m/z 720–900) was
observed to possess many similarities between the two methods
such as the ratio and abundance of ions at m/z 786.5 (PS 36 : 2),
788.5 (PS 36 : 1), 861.5 (PI 36 : 4), 863.5 (PI 36 : 3), and 885.5 (PI
38 : 4). The major diﬀerences seen between the spectra were the
chlorinated phosphotidylcholine adducts present in the TS
spectrum at m/z 792.5 (PC 34 : 2)/794.5 (PC 34 : 1), 818.5 (PC
36 : 3)/820.5 (PC 36 : 2), and 844.5 (PC 38 : 4)/846.5 (PC 38 : 3).
The chlorinated adducts in the TS spectrum indicate a lower
salt tolerance in TS than in DESI.25
In vitro detection of bacteria
Interest in in vitro detection and identication of bacteria by
mass spectrometry has increased signicantly.26 The ability to
directly detect biomolecules such as proteins and lipids by
matrix assisted laser desorption ionization (MALDI)27 and
electrospray ionization (ESI), respectively, has reduced diagnosis time while improving accuracy due to high molecular
specicity. Touch spray was investigated for its applicability to
in vitro detection. A minute amount of material, as little as 1%
of a single bacterial colony, was required for mass spectral
analysis. The data presented in Fig. 4 were acquired in the
negative ionization mode with automatic gain control (AGC) in
a burst of signal lasting just a few seconds. Repeated sampling
of the E. coli culture yielded ionized lipids of identical m/z values
and relative spectral intensity, while absolute intensity varied
with sampling. The spectra contained phospholipids in a prole
from approximately m/z 660–780, including odd-carbon number
fatty acid phospholipids (e.g. m/z 719.5, phosphatidylglycerol
32 : 1). It was determined empirically that the addition of
CHAPS, a surfactant, to the methanol spray solvent increased
signal and stabilized the TS spectra. Addition of CHAPS at
0.01% was determined to have the most benecial eﬀect
without undue interference from the CHAPS chloride adduct
(m/z 649.8). The observed surfactant eﬀect on improving spectra
in ambient ionization due to reduction in surface tension is well
known.28

Fig. 4 Negative ion mode TS-MS displaying E. coli phospholipids in a
sample consisting of 1% of a single colony, showing phospholipids and
the chloride adduct of CHAPS, a surfactant added to the spray solution.

This journal is © The Royal Society of Chemistry 2014
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Forensics: bulk and trace detection of illicit drugs
Forensics, in particular illicit drug analysis, oen requires the
ability to detect compounds in situ from matrices including
powders, drug residues on surfaces including clothing, and
illicit drugs in solution. Mass spectrometry is certainly capable
of analyzing all of these types of samples when using various
types of sample preparation. Touch spray oﬀers a method by
which to analyze these sample types without preparative steps.
Drug residues on clothing typically require extraction in
solvents whereas with TS the material can be lightly rubbed
absorbing minute amount of drugs while removing negligible
amounts of the cloth. This ability was demonstrated by the
detection of cocaine from a dried blood spot containing 10 ng of
the spiked drug on blue cloth, ESI Fig. 4†. A homogenous
solution containing 400 ppb each of MDMA, cocaine, and
methamphetamine was sampled by dipping the TS probe into
the solution and dried at ambient temperature (<1 minute). The
mass spectrum (Fig. 5) was recorded by the addition of spray
solvent and a high voltage; it displays the ions at m/z 150.3,
194.3, and 304.3 for each of the drugs in the solution,
respectively.
Therapeutic drugs
Therapeutic drug monitoring aids in maintaining drug
concentrations within the benecial range, maximizing therapeutic eﬀects while minimizing the risk of harmful overdosing
or wasteful undosing. Ambient ionization methods such as PS
have used whole dried blood or whole blood mixed with a
coagulant to quantitatively measure the concentrations of
pharmaceuticals.29 Whole bovine blood spiked with imatinib, a
therapeutic used for the treatment of chronic myelogenous
leukemia, and with its deuterated isotopomer added as internal
standard, were analyzed over a range of concentrations. Using
the teasing probe, blood was sampled by dipping once directly
into the blood to a xed depth, waiting <1 min to dry aer
dipping, and analyzing directly aerwards. The quantitative
performance was similar to that of PS with a linear response

Positive ion mode TS-MS of illicit drugs, methamphetamine,
MDMA, and cocaine, at 400 ppb in homogenous solution sampled via
a single dip of a touch spray probe.

Fig. 5
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Fig. 6 Full scan calibration curve of imatinib. Data points represent the
average value for repeat analysis (N ¼ 5) and error bars corresponding
to the standard deviation. Linear regression performed by unweighted
least squares analysis from 1 ppm to 13.3 ppm.

across the concentration range tested (Fig. 6).30 It could be
increased further using MS/MS. Furthermore, the percentage
error (n ¼ 5) was <10% for imatinib concentrations greater than
1 ppm, a value within FDA guidelines (see ESI Table 1†). It is
envisioned that a modied TS probe may be useful as a semiquantitative tool that could be used as a nger-prick device
which could be directly used to measure the concentration of
therapeutics in whole blood.
Residual agrochemical detection in foods
Agrochemicals are applied to foods in an attempt to prolong
crop quality while attempting to limit potentially adverse
health eﬀects. Oranges and other citrus fruits are commonly
treated (systemically or sprayed post-harvest) with fungicides
such as thiabendazole, leaving a trace amount of material on
the surface of the orange peel. Agrochemical levels are monitored and regulated in the United States, typically by chromatographic separation prior to MS analysis. This procedure is
not readily accomplished in situ, limiting thorough screening
of foodstuﬀs; however, fungicides have previously been reported to be monitored using paper spray ionization in situ.31 A
non-organic orange purchased from a national grocer was
subjected to analysis by TS, in which the probe was used to
sample 4 cm2 area of the peel. The spectrum, ESI Fig. 5,†
includes ions due to protonated thiabendazole (m/z 202) and
imazalil (m/z 297). The acquired spectrum matches previously
reported fungicides detected from non-organic oranges using
an alternative ambient ionization method (i.e. low temperature
plasma).22
Elaborations
Reactive touch spray ionization. TS-MS experiments
exploiting simultaneous chemical derivatization and ionization
(i.e. reactive ambient ionization) were explored. Derivatized
versions of analytes oen give greater signals in MS analysis of
complex mixtures. The use of appropriate reagents allows
reduction of complex spectra via analyte signal enhancement or
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characteristic m/z value shis. Reactive touch spray was
explored with known types of ambient reactions including noncovalent adduct formation, (e.g. silver adduction of olens32)
and covalent bond formation (e.g. betaine aldehyde with alcohols33). Cholesteryl linoleate and adrenosterone were sampled
from homogenous solution in a dipping fashion by TS. The
unsaturated aliphatic functionality of cholesteroyl lineolate
reacted with silver nitrate (4 ppm, acetonitrile) forming noncovalent adducts detected at m/z 755.4 and 757.4 (ESI Fig. 6†)
corresponding to [107Ag + cholesteroyl lineolate] and [109Ag +
cholesteroyl lineolate]. Covalent bond forming reactions targeting the ketone functional group in adrenosterone, a cholesterol-related hormone, were accomplished using Girard's
Reagent P and hydroxylamine (ESI Fig. 7†). The detection of
cholesterol from bovine blood was accomplished using betaine
aldehyde which reacts with a poorly ionizable hydroxyl functionality creating a positively-charged quaternary amine derivative (ESI Fig. 8†).
Continuous touch spray ionization. Most applications of
touch spray only require brief recording of the MS signal to
obtain the desired information, as outlined above. However, if
the application dictates a longer signal duration, touch spray
can be coupled to a solvent delivery system (solvent pump) to
provide solvent at controlled ow rate to produce stable ion
currents. The solvent is added continuously at the same location where discrete additions of solvent produce spectra,
yielding a signal that lasts until analyte exhaustion. An illustrative gure is presented in ESI Fig. 9† including parameters
determined used with the bent teasing probe.

Conclusions
Touch spray (TS) ionization is a spray-based ambient ionization method capable of in situ sampling of complex mixtures.
Rapid, reproducible, and specic chemical information is
obtainable from biological tissue including mouse brain and
human prostate cancer. Diﬀerentiation of specic anatomical
regions and disease states based on lipids detected in the
negative ionization mode appears to be possible. Application
in the detection of bacteria is promising, the detected lipids
allowing for diﬀerentiation of bacteria. TS-MS of solutions,
including blood, could allow for numerous applications in
forensics (e.g. illicit drugs) and medicine (e.g. therapeutic drug
monitoring). The user-guided nature of TS allows for the
unique sampling abilities while hindering absolute quantitation. Further, as is the case for many ambient ionization
techniques, simultaneous ionization and chemical derivatization enhances the signal for specic analytes or groups of
analytes.
Further development of TS-MS including the sampling
methodology, probe design, and probe material could lead
to improved quantitative performance and reproducibility.
The ultimate application of the TS technology would be
in combination with miniaturized mass spectrometer
systems to allow for in situ sampling, ionization, and mass
analysis.

This journal is © The Royal Society of Chemistry 2014
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multiple variants also were tested.
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The spray solvent used for MS acquisition was methanol,
purchased from Mallinckrodt Baker Inc. (Phillipsburg, NJ), and
applied manually via an adjustable pipette (Eppendorf
Research-2.5 mL). Additional spray additives including 3[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate
(CHAPS) was purchased from Sigma-Aldrich (St. Louis, MO).
Therapeutic drugs were acquired from Cerilliant (Round Rock,
Texas, USA). Drugs were stored at 20  C until diluted in bovine
blood to appropriate concentrations. Illicit drugs were acquired
from Cerilliant (Round Rock, Texas, USA). Drugs were stored at
20  C until diluted to appropriate concentrations. Nonorganic orange was purchased from national grocer for agrochemical MS experiments.

Mouse brain tissue
Mouse brain tissue was acquired from JAX® Mice and Services
(Bar Harbor, Maine, USA). A mouse brains was sectioned at 15
mm and thaw mounted onto glass microscope slides. The slides
were stored in closed containers at 20  C; prior to analysis they
were allowed to come to room temperature and dried in an
electronic desiccator for approximately 20 minutes.

Prostate tissue
Radical prostatectomy specimens were obtained from consented patients via Indiana School of Medicine (Indianapolis,
IN). Biopsies were obtained using a disposable biopsy gun in
accordance with an IRB approved protocol. Biopsies were
frozen, cryosectioned at 15 mm and thaw mounted to glass
microscope slides. Sections were stored at 80  C prior to
analysis. Histopathology was performed upon H&E staining
prostate biopsies by an expert pathology.

Bacteria culturing
E. coli strains were supplied by bioMérieux, Inc. (Hazelwood,
MO) and cultured from frozen samples stored at 80  C in
TSAB. Bacteria were cultured on TSA with 5% sheep blood
(Remel, Lenexa, KS) and incubated in a VWR incubator (Chicago, IL) at 37  1  C for approximately 24 h, sub-cultured for an
additional 24 h, and then used in TS-MS experiments.

Instrumentation
A LTQ linear ion trap (Thermo Fisher Scientic) was used in
experiments unless otherwise specied and carried out with the
auto gain control (AGC) activated.

This journal is © The Royal Society of Chemistry 2014
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Diﬀerentiation of prostate cancer from normal
tissue in radical prostatectomy specimens by
desorption electrospray ionization and touch
spray ionization mass spectrometry†
K. S. Kerian,a A. K. Jarmusch,a V. Pirro,a M. O. Koch,b T. A. Masterson,b L. Chengc and
R. G. Cooks*a
Radical prostatectomy is a common treatment option for prostate cancer before it has spread beyond the
prostate. Examination for surgical margins is performed post-operatively with positive margins reported
to occur in 6.5–32% of cases. Rapid identiﬁcation of cancerous tissue during surgery could improve surgical resection. Desorption electrospray ionization (DESI) is an ambient ionization method which produces
mass spectra dominated by lipid signals directly from prostate tissue. With the use of multivariate statistics,
these mass spectra can be used to diﬀerentiate cancerous and normal tissue. The method was applied to
100 samples from 12 human patients to create a training set of MS data. The quality of the discrimination
achieved was evaluated using principal component analysis – linear discriminant analysis (PCA-LDA) and
conﬁrmed by histopathology. Cross validation (PCA-LDA) showed >95% accuracy. An even faster and
more convenient method, touch spray (TS) mass spectrometry, not previously tested to diﬀerentiate diseased tissue, was also evaluated by building a similar MS data base characteristic of tumor and normal
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tissue. An independent set of 70 non-targeted biopsies from six patients was then used to record lipid
proﬁle data resulting in 110 data points for an evaluation dataset for TS-MS. This method gave prediction
success rates measured against histopathology of 93%. These results suggest that DESI and TS could be
useful in diﬀerentiating tumor and normal prostate tissue at surgical margins and that these methods
should be evaluated intra-operatively.

Introduction
Prostate cancer is estimated to be the most commonly diagnosed cancer in the United States, representing 14% (233,000
cases) of all newly diagnosed cancer cases in 2014.1 Treatments for prostate cancer include surgery, radiation therapy,
and hormone therapy, the choice between them being primarily dependent on the patient’s health and the stage of the
cancer. At the time of diagnosis, over 90% of prostate cancer
cases have tumors confined to the prostate gland, representing
stage 1 or stage 2. Before cancer has spread to the outer
layer of the prostate, the disease is curable through complete
a
Purdue University, Department of Chemistry and Center for Analytical
Instrumentation Development, Purdue University, West Lafayette, IN 47907, USA.
E-mail: cooks@purdue.edu
b
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† Electronic supplementary information (ESI) available. See DOI: 10.1039/
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surgical resection by radical prostatectomy (RP).2 Standard
practice relies on preoperative measurements such as rectal
examination and clinical biopsy data to guide surgical resection. Positive surgical margins are only identified after completion of the surgery and their incidence is reported to range
from 6.5–32%.3
Needle biopsies are used for early diagnosis of prostate
cancer, however cancer detection using such biopsies is prone
to false negatives, reportedly up to 25%.4 Diﬃculty in diagnosis is the result of the limited sample size, the limited number
of malignant glands among many benign, and confusion of
benign histological features which mimic prostate cancer such
as paraganglia or xanthoma. Immunohistochemistry (IHC) has
been used to label p63, a marker for basal cells, which is
present in benign and absent in cancerous tissue. However,
negative staining is not reliably diagnostic given the limited
number and sizes of samples. Positive staining for α-methylacyl-CoA racemase (AMACR) can be used since it is greatly upregulated in cancer, but this method too has pitfalls with
false negative rates up to 20–30% in cases such as pseudohyperplastic, atrophic, and foamy gland adenocarcinoma of
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the prostate.5 Currently unrepresented in prostate molecular
diagnostics is the use of the lipid constituents of tissue,
either in early diagnosis or in post-surgical tumor margin
diagnostics.
Lipid constituents of tissues are readily measured by
ambient ionization MS methods such as desorption electrospray ionization MS (DESI-MS). The basis for ambient ionization is sample examination in the ambient environment with
little to no prior sample preparation.6 The two methods used
in this study, DESI and touch spray (TS) ionization7 fall into
this category as do others like nanospray desorption electrospray ionization (nanoDESI),8 probe electrospray ionization
(PESI)9 and laser ablation electrospray ionization (LAESI).10
A number of recent studies have reported the application of
mass spectrometry (MS) as a molecular diagnostic tool for
cancer. Zare and coworkers used DESI imaging with statistical
analysis methods to classify gastrointestinal cancer tissues
from banked and surgical specimens.11 Agar and coworkers
showed that it is possible to distinguish diseased from healthy
brain tissue using a library of mass spectra characteristic of
particular disease states.12 The work on brain cancer has
allowed clear diﬀerentiation of healthy from diseased tissue as
well as glioma subtype, the stage of the disease in particular
tumor regions, and the tumor cell concentrations at particular
locations.13 Another mass spectrometry method, ultraperformance liquid chromatography MS, has been shown to accurately identify prostate cancer from serum using a metabolitebased assay.14 It is possible to recognize in these and related
studies the beginnings of a significant eﬀort to perform cancer
molecular diagnostics through the use of mass spectrometry
(MS).
The origins of recent interest in diagnostics by mass spectrometry can be traced to the development of matrix-assisted
laser desorption ionization (MALDI) imaging and its application to mapping the distribution of proteins and peptides in
tissue sections.15,16 Ambient ionization methods which do not
use matrices have also given highly encouraging results,
especially for small molecules including drug metabolites,
hormones and lipids.17 The earliest application of DESI to
cancer diagnosis demonstrated changes in lipid profiles in
normal human liver tissue compared to metastatic liver adenocarcinoma. This study established the fact that tumor margins
can be recognized by mass spectrometry imaging.18 Subsequent work using DESI diﬀerentiated tumor from normal
tissue using lipid profiles in kidney cancer,19 bladder cancer,20
testicular cancer,21 and brain cancer.12,13,22,23 The development of ambient ionization methods for cancer diagnostics
was accelerated by the rapid evaporative ionization mass spectrometry experiments of Takáts and coworkers.24 In this
approach, the smoke produced during electrosurgical dissection is transferred and analyzed by a mass spectrometer. The
smoke contains phospholipids and other biomolecules
released from the region being resected and comparison to a
library of spectra allows tissue identification. DESI and TS
are both spray-based ambient ionization methods. However,
their respective features make them suitable for diﬀerent
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tasks. DESI-MS is primarily an imaging technique, allowing
collection of mass spectra, pixel by pixel, to create 2D molecular images. The collected data can be assembled in hyperspectral datacubes25 from which 2D ion images corresponding
to specific components can be extracted to show the spatial
distribution and relative amounts of analytes. Applications of
DESI in distinguishing diseased and non-diseased tissue rely
on the use of multivariate statistics,25 typically principal component analysis (PCA) and partial least squares discriminant
analysis (PLS-DA). DESI provides a key connection between the
information from histopathology and the characteristic mass
spectrum that is produced for each tissue and disease type
because the same (or adjacent) tissue sections analyzed by
DESI can be evaluated by the pathologist. On the other hand,
TS-MS is a user-guided method in which a spot of interest is
directly sampled with a probe, e.g. teasing needle, and transferred to the interface of a mass spectrometer, and ionized
by the application of solvent and high voltage. TS produces
information rich spectra which are similar to DESI, but in a
localized and very rapid process which typically takes a few
seconds.
We explore the potential of DESI-MS and TS-MS for prostate
cancer diﬀerentiation through in vitro analysis of radical prostatectomy specimens. First, DESI-MS was used to establish the
relationship of MS features to pathology and then touch spray
was used to characterize unknown tissue samples. Training
sets for both methods were built using data obtained from 12
radical prostatectomy specimens and evaluated by PCA and
linear discriminant analysis (LDA). Both methods resulted in
>95% correct sample identification when confirmed against
histopathology. A TS-MS test dataset, obtained from another
six radical prostatectomy specimens, was used for further
evaluation of the method using a non-targeted analysis of the
prostate tissue samples.

Results and discussion
DESI and TS lipid profiles and training datasets
Prostate cancer is a heterogeneous disease. It is commonly
diagnosed by histopathology which at times can be ambiguous. The morphological variations that are the basis for diagnosis by histology result from underlying biochemical
changes. The two main criteria for diagnosis are atypical
architectural features (e.g. perineural infiltration) and atypical
cytological features (e.g. enlarged nuclei). Prostate cancer diagnosis does not currently use the lipid components of the cancerous cells or tissue. Thus, complementary information
provided by direct molecular diagnosis of prostate cancer by
mass spectrometry could be useful to improve decisionmaking strategies. In this study, two diﬀerent ionization techniques, DESI and TS, were used to acquire lipid profiles and
investigate diﬀerences between tumor and normal tissue. The
biochemical features recovered by DESI and TS were also compared, since each ambient ionization technique provides
unique capabilities.
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For prostate tissue, the primary components of lipid profiles (detected as negative ions) are glycerophospholipids:
phosphotidylethanolamines (PhE), phosphotidylserines (PhS),
phosphotidylcholines (PhC), and phosphatidylinositols (PhI).
These lipids can be observed in the average normal
(74 samples) and tumor (26 samples) mass spectra shown in
Fig. 1 for DESI (A and B) and TS (C and D). Many of the same
diﬀerences between normal tissue and tumor are seen in both
DESI and TS average spectra. These include ratio changes for
ions m/z 788 and 885, an increase in relative abundance of
ions m/z 786, 835, 861, 863, and a decrease in relative abundance of ions such as m/z 737. However, there are also diﬀerences in the mass spectra recorded by DESI and TS (Fig. 1A vs.
D, Fig. 1B vs. E). For example, chlorinated adducts of phosphatidylcholine species (e.g. m/z 794) are more abundant in

Analyst

the TS than the DESI spectra (as well in the case of m/z 794
being more abundant in tumor than in normal tissue). This
example suggests that some diﬀerences between the ionization
methods can be attributed to diﬀerent salt content tolerances
(TS has a lower salt tolerance than DESI) in the complex
matrix when analyzed with no sample pretreatment, as discussed elsewhere.8 The same spectra also show that the
average ion intensity in TS is two orders of magnitude greater
than that in DESI, suggesting that extraction/desorption occurs
more rapidly in comparison to DESI. Considering the lipid
profiles recorded for the entire dataset, 12 patients and 100
samples (thousands of mass spectra), the diﬀerences between
disease states are diﬃcult to address by eye therefore a robust
statistical strategy is needed to eﬃciently explore the chemical
information contained in the mass spectra. PCA was

Fig. 1 (A) Average DESI-MS of normal prostate tissue samples (N = 74) from training set. (B) Average DESI-MS of prostate cancer tissue samples (N =
26) from training set. (C) Prostate tissue biopsy with outlined region of cancerous tissue which was analyzed by DESI imaging. (D) Average TS-MS of
normal prostate tissue samples (N = 74) from training set. (E) Average TS-MS of prostate cancer tissue samples (N = 26) from training set. (F) Prostate
tissue biopsy analyzed by TS-MS, tissue is adjacent to DESI imaged biopsy again the cancerous region outlined, the two missing regions correspond
to locations of TS-MS analysis.
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In this case, the best separation among red and dark green
objects is in the PC3 vs. PC4 score plot and is associated with
a slightly lower percentage of the total data variation. By contrast, DESI mass spectra result from averaging many pixels in
the hyperspectral images, selected as regions of interest
(tumor or normal tissue sections) and this helps reduce
random noise. In DESI, the best separation is along PC2
vs. PC3.
Independently of the ionization method used for analysis,
the loading plots display a similar relationship between the
objects and variables. This observation provides initial insight
into the consistency between DESI and TS in recovering the
biochemical features associated with the tumor/normal condition. In particular, the ions m/z 835, 861, 885, and 887 are
higher in relative abundance in prostate cancer tissue, while
m/z 788 is higher in relative abundance in normal prostate
tissue. It is noteworthy that the ions observed in higher abundance in prostate cancer tissue correspond to phosphatidylinositol species: PhI(38:4), PhI(38:3), PhI(36:4), and PhI(34:5)
respectively. Oncogenes (e.g. PI3K, AKT, PTEN) pertaining to
lipid-based signaling are relevant to prostate and other human
cancers.26–28 Intriguingly, the dynamics in the PhI class of glycerophospholipids could relate to PI3K, an oncogene which
utilizes phosphorylated-PhIs (not directly detected here) for
cancer cell growth and survival signaling.29 The observed
increase in non-phosphorylated PhIs might prove to have an
unexplored but important role in prostate cancer.

Fig. 2 (A) DESI-MS score plot, PC2 vs. PC3, displaying separation of
prostate cancer (red objects) and normal prostate tissue samples (dark
green objects). (B) TS-MS score plot, PC3 vs. PC4, displaying separation
of prostate cancer (red objects) and normal prostate tissue samples
(dark green objects).

performed as an exploratory tool to identify chemical features
that characterize tumor and normal tissue based on the DESI
and TS lipid profiles. The PCA score plots are shown in Fig. 2A
and B, respectively for DESI and TS. Both plots show the
lowest-order principal components (PCs) for which separation
between normal and tumor tissue is apparent. Indeed, distinct
groupings of normal (dark green objects) and tumor tissue
samples (red objects) are present. The loading plots shown in
ESI† Fig. 1A and B display those lipids that contribute the
most to the PC diﬀerentiation.
The first principal component by definition encompasses
the largest variation in the multidimensional space of the original variables, PC2 is orthogonal and includes the largest
remaining variation, etc. Separation in PC space between
normal and tumor tissue is interpreted in terms of diﬀerences
between their DESI (and TS) mass spectra (i.e. biochemical
features). The TS spectra are usually noisier than the DESI
spectra, which may be attributed to the smaller number of
scans acquired over a shorter time before signal exhaustion.

This journal is © The Royal Society of Chemistry 2015

Classification of prostate cancer/normal tissue by molecular
profiling
LDA was performed on the DESI and TS target datasets (data
that was directly correlated to identified tumor or normal
samples by histopathology) to quantify the separation between
normal and tumor samples and build a classification model
capable of predicting the disease state of unknown samples.
The first eight and nine PCs were used for DESI and TS datasets, respectively, which provided the highest prediction rates
for both classes (normal and tumor tissue). The average crossvalidation (CV) prediction rate was 98% for DESI and 96% for
TS. The number of false results per class obtained through the
cross-validation process can be seen in Table 1, where the CV
confusion matrices are reported. Notably, DESI performs
slightly better than TS-MS, although both methods exceed
95% in correct predictions.
Table 1

Cross validation of training set

(A) DESI-MS CV prediction rates
Normal
98.7%
Tumor
96.2%
Average
97.5%
(B) DESI-MS CV confusion
matrix
Species
Normal
Tumor
Normal
73
1
Tumor
1
25

(C) TS-MS CV prediction rates
Normal
96.1%
Tumor
95.8%
Average
96%
(D) TS-MS CV confusion matrix
Species
Normal
Tumor

Normal
73
1

Tumor
3
23
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(A) TS-MS stepwise LDA on the
targeted dataset
Normal
100%
Tumor
100%
Average
100%
(B) TS-MS stepwise LDA targeted
confusion matrix
Species
Normal
Tumor
Normal
74
0
Tumor
0
26

(C) TS-MS untargeted prediction
rates
Normal
96%
Tumor
89%
Average
92.5%
(D) TS-MS untargeted confusion
matrix
Species
Normal
Tumor
Normal
97
4
Tumor
1
8

To further test the performance of TS-MS, which was used
here for the first time to diﬀerentiate diseased and healthy
tissue, an additional evaluation set was tested. Samples were
acquired from patients #13–18 and a total number of 70 biopsies were performed from which 110 samples were analyzed
randomly. The LDA model built on the target TS dataset was
used to predict the tissue condition (tumor or normal) of
these unknown samples. The LDA predictions, based on MS
molecular diagnostics, were compared with pathological evaluation of adjacent, unanalysed, tissue sections. Nine samples
were diagnosed as prostate cancer by an expert pathologist,
while the remaining 101 samples were normal tissue. The LDA
results were only moderately discriminatory which we attribute
to the low reproducibility of some ions (e.g. chloride adducts)
in the TS evaluation set of spectra which were acquired in full
scan MS mode at a later date then the TS test set. We therefore
built an LDA model using the top five discriminant ions in the
range m/z 700–1000, as opposed to compressing the entire
mass spectra by PCA, using a stepwise variable selection strategy to select the most discriminant ions.30 This strategy proved
more eﬃcient and robust in diﬀerentiating tumor and normal
tissue for the TS target dataset (see Table 2), no prediction
errors in cross validation. Moreover, the average percentage of
correct prediction of tumor and normal tissue for the external
evaluation set (110 samples) was equal to 93%. It should be
noted that the small number of samples with tumor tissue was
due to the non-targeted selection of the samples analyzed.
These results suggest that further refinements of the strategy
used for data analysis could strengthen a decision-making
strategy based on molecular diagnostics. A wide portfolio of
pretreatment processes and variable selection techniques is
available for pattern recognition analysis, following the needs
of the acquired MS data structures.

DESI and TS similarities and fit-for-purpose applications
The similarities between DESI and TS mass spectra in providing chemical features associated with a healthy/disease state is
of interest. Indeed, although based on similar mechanisms of
ion generation (i.e. electrospray-like processes), DESI and TS
have specific analytical features that may be used to propose
diverse fit-for-purpose strategies of molecular diagnostics. To
estimate the correlation between the two sets of MS data, canonical correlation analysis (CCA) was performed on the DESI
and TS target datasets (100 samples). Fig. 3 shows the samples
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Fig. 3 (A) Canonical variable 1 vs. 2 score plot displaying separation of
tumor (red objects) and normal tissue samples (dark green objects) for
DESI-MS target dataset. (B) Canonical variable 1 vs. 2 score plot displaying separation of tumor (red objects) and normal tissue samples (dark
green objects) for TS-MS target dataset.

in the canonical variable space (1 vs. 2) for DESI and TS with a
clear separation between tumor (red) and normal tissue
samples (dark green). The correlation coeﬃcients for the first
three canonical variables are as high as 0.94, 0.76, and 0.68
respectively (ESI† Fig. 2). The high correlation between DESI
and TS is also supported by the location of each sample
(labelled with the same sample number in both plots) in the
CCA space. The loading plots (ESI† Fig. 3) show the greatest
contribution to the canonical variable computation from principal components 1, 2, and 3 for DESI, whereas principal components 2, 3, and 4 have the highest contribution for TS. Most
importantly, the high correlation between DESI and TS data is
related to the principal components that carry the biochemical
information relevant to separating tumor and normal tissue
samples.
CCA results suggest that the same interpretations regarding
the chemical features which characterize tumor and normal
tissue can be applied to DESI and TS spectral patterns. This
suggests that both methods have similar diagnostic performance but with diﬀerent, possibly complementary, implementations as now discussed. One of the most important features
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sampling requires more time. The limited sample size collected by the TS probe also forces the user to carefully consider
the measurement uncertainty due to sampling, which may
bias the analytical results.
TS-MS is envisioned as a surgical tool for disease screening of
areas of interest. As a surgical screening tool, TS could help preserve healthy tissue that may have otherwise been resected for
histopathological evaluation or help with decisions to remove
additional diseased tissue that was observed to be questionable.

Conclusions
DESI-MS and TS-MS have been used to diﬀerentiate tumor and
normal tissue from biopsies taken from 18 radical prostatectomy surgical specimens. The targeted dataset (radical prostatectomy specimen 1–12) was subjected to discriminant
classification analysis using LDA, providing an average prediction rate of 97.5% for DESI-MS and 96% for TS-MS. Validation
of TS-MS as a non-targeted technique was performed using an
external evaluation set (radical prostatectomy specimen 13–18)
of unknown prostate specimens, which provided average predictions rates of 92.5%. DESI and TS results are comparable
(0.94 correlation coeﬃcient by CCA), recovering the biochemical information, primarily in the lipids, that is responsible for
the separation of tumor and normal prostate tissue samples.

Fig. 4 (A) TS-MS obtained in vitro from radical prostatectomy case 19,
lipid pattern suggests sampled area was cancerous and this agrees with
gross pathology ﬁndings. (B) TS-MS obtained from targeted cancer
sample from training set.

of TS is its use of the probe as means of sampling a complex
matrix as well as serving as a source of the ions which move into
the mass spectrometer upon the addition of solvent and high
voltage. This transfer mechanism makes TS completely userguided and applicable to a variety of samples. TS is not limited
to tissue sections, but can be used to investigate areas of
interest in vivo. Fig. 4 shows the degree of similarity of (A) a
TS mass spectrum obtained by sampling a bisected radical
prostatectomy specimen in vitro and (B) a TS mass spectrum
obtained from a frozen tissue section from the training set.
The complete TS process of sampling to collecting data can
occur within 20 seconds. Similar lipid profiles are obtained for
DESI and TS, even though comparisons between in vitro and
in vivo TS analysis, as well as sources of contamination
aﬀecting the mass spectra, e.g. blood, urine etc., need further
investigation.
Limited sample size is the main disadvantage of TS-MS.
The minimal removal of material from a sensitive source such
as tissue is viewed as an advantage for the patient, but it limits
the power of the technique by reducing analysis to a few MS
scans before the signal is exhausted. This could be overcome
by multiple examination of the same area, but each additional

This journal is © The Royal Society of Chemistry 2015

Experimental
Study protocols
Radical prostatectomy specimens #1–19 were obtained from
consented patients undergoing treatment at Indiana School of
Medicine (Indianapolis, IN) following an IRB approved study.
Biopsies were obtained from specimens #1–18 after resection
using a disposable biopsy gun (Max-core disposable core
biopsy instrument, Bard Biopsy Systems, Tempe, AZ). Biopsies
(approximately 4–15 mm × 1 mm × 1 mm) were subsequently
frozen, cryosectioned at 15 μm, and thaw mounted to glass
microscope slides. Sections were stored at −80 °C prior to MS
analysis. The same slide analyzed by DESI-MS imaging was
H&E stained and examined by an expert pathologist to identify
from tissue morphology the presence/absence of prostate
cancer. Adjacent sections (separated by ∼15–60 μm) were analyzed by TS-MS by sampling areas of 1–4 mm2 from regions of
known pathology based on the DESI/histopathology assignment of locations as diseased or normal tissue. Note that this
procedure was necessary because TS is a destructive sampling
method for thin sections. Radical prostatectomy specimen #19
was inked according to IUSM gross pathology protocol then
bisected to allow the tissue to be analyzed in vitro. The specimen was analyzed by TS-MS at IUSM using an on-site commercial mass spectrometer. No biopsies were taken from specimen
#19 and thus no DESI-MS analysis was performed. Radical
prostatectomy specimen #19 results were compared to gross
pathological analysis obtained from IUSM.
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A total of 100 samples were prepared from patients # 1–12
and used to create a database of tumor and normal tissue
mass spectra for both DESI and TS methods. These databases
are referred to as targeted datasets, because the data used is
directly correlated with histopathological analysis of the tissue.
For the DESI targeted datasets, regions outlined as tumor or
normal by pathology were selected (∼4 mm2 on average) and
data were averaged to create each data point for subsequent
multivariate analysis. In parallel, TS was performed in the
regions outlined as tumor or normal tissue from adjacent
tissue sections used for DESI and that data was directly used
to create the TS targeted dataset. Table S1† shows in detail the
number of sections prepared per biopsy and patient. Another
70 biopsies were prepared from the other 6 radical prostatectomy specimens ( patients # 13–18) and these were analyzed
only by TS-MS to create an evaluation dataset to further test
performance. The biopsy sections used to create this independent evaluation dataset were randomly chosen and sampled
1–2 times (depending on the size of the tissue) to create a 110
sample dataset. Also included in the evaluation set were 1–2
randomly selected samples from each patient used in the targeted dataset. Histopathology of these tissue sections was performed after MS analysis on adjacent tissue (spacing
∼15–60 μm).
DESI-MS
A laboratory-built DESI ion source, similar to the commercial
2D source from Prosolia, Inc. (Indianapolis, IN, USA) was
coupled to a linear ion trap mass spectrometer (LTQ) controlled by XCalibur 2.0 software (ThermoFisher Scientific,
Waltham, MA) and used in DESI experiments. The negative
ionization mode was used with the automatic gain control
(AGC) inactivated. The spray solvent used for DESI-MS was
dimethylformamide (DMF)–acetonitrile (ACN) at a 1 : 1 ratio
(v/v), both solvents were purchased from Mallinckrodt Baker
Inc. (Phillipsburg, NJ), and delivered at 1.0 μL min−1 flow rate
using the instrument syringe pump. The DESI source parameters were set as follows: capillary temperature 275 °C,
voltage applied to the stainless steel needle syringe 5 kV, capillary voltage −25 V, tube lens voltage −115 V, capillary incident
angle 54°, spray to surface distance ∼3 mm, sample to inlet
distance ∼5 mm, and nitrogen gas at 180 PSI. Prostate tissue
sections were analyzed using a moving stage with a lateral
scan rate of 303.03 μm s−1 in horizontal rows separated by a
200 μm vertical step. Instrument scan time was coordinated
with scan speed providing ∼200 × 200 μm pixels. Full scan
mass spectra were acquired in negative ion mode in the mass
range m/z 200–1000. For statistical analysis of the evaluation
dataset, a reduced mass range of 700–1000 was used, limiting
the biochemical information to complex phospholipids.
Touch spray MS
The TS probe used was a commercially available teasing
needle purchased from Fisher Scientific (Pittsburgh, PA,
USA).7 Methanol (Mallinckrodt Baker Inc., Phillipsburg, NJ)
was used as spray solvent and 1 μL was applied manually via
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an adjustable pipette (Eppendorf Research-2.5 μL). The LTQ
linear ion trap mass spectrometer was also used for the TS
experiments with the same operating parameters as those
used in the DESI experiments except that the voltage applied
to the TS probe was 4 kV and the automatic gain control was
active. TS was performed by touching and desorbing material
onto a teasing needle from regions of interest of 1–4 mm2.
After sampling, the tip of the probe was directed at the inlet of
the mass spectrometer and the high voltage and 1 μL of
solvent were applied. The extracted analytes were analyzed in a
spray time of ∼6 seconds. The data acquired within this period
were averaged to represent a single data point.
Principal component analysis of target datasets
An in-house program was used to convert the MS data files
(.raw) into ASCII files (.txt), which were imported into Matlab
(MathWorks, Inc., Natick, USA). Biomap software (http://www.
maldi-msi.org) was used to display single ion images (i.e.
spatial distribution of a single m/z variable, ESI† Fig. 4) with
MS intensity represented in false color (normalized to the
absolute value). For each DESI image, information was coded
as a datacube (X·Y·MS), where “X” and “Y” are spatial dimensions and the “MS” domain contains the m/z variables and
corresponding intensity (i.e. an entire mass spectrum). Groupings of adjacent pixels, i.e. regions-of-interest (ROIs), representing areas of tumor or normal tissue were selected in the
2D spatial domain (X·Y), according to pathological evaluations,
and the corresponding mass spectra were averaged. The averaged mass spectra from the prostate sections constituted the
DESI target dataset. The TS target dataset was built using a list
of m/z values and ion abundances from the average mass spectrum (over ∼6 s of data acquisition) acquired per sample. The
data were then imported into Matlab.
The acquisition step used to increment m/z values was
equal to 0.0833, therefore the two data matrices (DESI and TS)
consisted of 3601 columns (i.e. m/z values) and 100 rows (i.e.
samples: normal tissue sections, n = 74; tumor tissue sections,
n = 26). PCA was performed with in-house Matlab routines.
PCA is commonly used for exploring complex information contained within mass spectral datasets, allowing consideration of
all spectral variables and possible inter-correlations simultaneously.25,31 By means of PCA, the information of the original m/z variables is reorganized and compacted in a few
principal components (PCs). That is, PCA can be used as an
unsupervised data compression technique. When dealing with
high-dimensional data, the compression of the relevant information is a preliminary step in order to eﬃciently manage and
extract useful features. All MS spectra were normalized by the
standard normal variate (SNV) transform, correcting for both
baseline shifts and global intensity variations,32,33 and then
column centered. The principal components are orthogonal
(i.e. uncorrelated) and eﬃciently describe large fractions of the
information. The projections of the data objects onto the PCs
are called scores, while the importance of each original variable in defining a certain PC is given by a loading coeﬃcient.
Groupings in the score plot indicate similarities among
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the objects (i.e. samples), based on the information derived
from the mass spectra. Both scores and loading values were
represented in two-dimensional scatter plots.
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Canonical correlation analysis on the target datasets
Canonical correlation analysis (CCA) is a way of measuring the
linear relationship between two multidimensional variables
(DESI and TS) observed on the same sample collection.34,35 In
this study, the two datasets represent the DESI and TS mass
spectra recorded from 100 prostate tissue sections. The DESI
mass spectral dataset is considered as a reference. CCA rotates
the original variables in the two blocks, to obtain some pairs
of variables (one for each block), called canonical variables,
with maximum correlation between the two blocks. The
dimensionality of these new bases is equal to or less than the
smallest dimensionality of the two sets of variables. The canonical variables are linear combinations of the original autoscaled (i.e. unitary variance) variables, whose contribution in
defining a specific canonical variable can be inferred through
the corresponding loading value. The correlation coeﬃcients
between the DESI canonical variable and the corresponding TS
canonical variable are termed canonical correlation coeﬃcients. Specific details on CCA can be found elsewhere.34,35 In
order to overcome the high inter-correlations across m/z
values, CCA was performed after PCA, which acts as an unsupervised data compression technique. Two separate PCAs
were run on the SNV normalized and column-centered DESI
and TS mass spectral data. The first 10 PCs, explaining about
90% of total data variation, were selected and used for CCA.
CCA was performed by the free chemometric package
V-PARVUS 2010 (University of Genova, Italy, (http://www.csita.
unige.it/software/free/other.html).
Linear discriminant analysis on the target and the evaluation
sets
Linear discriminant analysis (LDA) was performed as a supervised discriminant classification technique. Discriminant
methods look for a delimiter that divides the global domain
into a number of regions, each assigned to one of the classes.
This delimiter identifies an open region for each class and
such regions determine the assignment of the samples to one
of the classes.30,36 Model validation (i.e. evaluation of the predictive ability of the model) was performed by means of cross
validation (CV).36 For this study, five cross-validation deletion
groups were selected, meaning that all the samples (n = 100)
were divided five times systematically in a training set (objects
used for building the classification model) and a test set
(remaining objects used to evaluate the predictive ability of the
model), with all the samples being in the test set only once.
Eventually, the final model was built using all the objects. LDA
was applied on the DESI and TS target datasets of SNV normalized mass spectra after compression by PCA, thereby using as
variables the principal components (instead of the original
mass spectral data). Two classes were modelled: normal tissue
(n = 74) and tumor (n = 26). In more detail, 8 PCs for DESI and
9 PCs for TS were computed each time with the training
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samples and used for building the classification model. The
test sets – samples that did not contribute in the model building process – were used to estimate the global prediction rate
for all classes, hence as the CV prediction rate for each class.
This is a so-called complete validation strategy.36 The CV prediction rate is the percentage of correct predictions on the
objects in the CV test sets. The CV confusion matrix shows
how many samples belonging to a certain category were correctly/incorrectly assigned by the classification rule to that category. Indeed, in this matrix, each element gives the number
of samples of the row category assigned to the column category. When the matrix is diagonal (entries outside the main
diagonal are all zero) there is a perfect prediction of all the
samples. Note that LDA models used for supervised discriminant classification were built by using 4 to 10 PCs. The models
with 8 and 9 PCs, for DESI and TS respectively, were chosen as
they provided the least number of false results (i.e. highest prediction rates) in cross-validation.
The model built for the TS dataset was used further to
predict the normal/disease state of another 110 samples (the
evaluation set), whose histopathology was unknown at the
time of MS analysis. The subsequent comparison between
molecular diagnosis by TS-MS and histological diagnosis
further validated the TS-MS model performances. LDA was performed with Matlab using in-house routines.

Acknowledgements
Funding for this research was supported by grants from the
National Institute of Health (1R21EB009459-01), the National
Institute of Biomedical Imaging and Bioengineering
(1R21EB015722-01A1) and the Purdue University Center for
Cancer Research. The authors thank Timothy Ratliﬀ for valuable discussions and Dr Paolo Oliveri (University of Genova,
Italy) for proving the in-house Matlab routines. This work was
performed within the limits of approved IRBs: Purdue protocol
(1203011967) and Indiana University protocol (1205008669).

Notes and references
1 National Cancer Institute. Prostate Cancer, http://www.
cancer.gov/cancertopics/types/prostateaccessed Jul 28, 2014,
vol. 2014.
2 A. Tewari, P. Sooriakumaran, D. A. Bloch, U. SeshadriKreaden, A. E. Hebert and P. Wiklund, Eur. Urol., 2012, 62,
1–15.
3 O. Yossepowitch, A. Briganti, J. A. Eastham, J. Epstein,
M. Graefen, R. Montironi and K. Touijer, Eur. Urol., 2014,
65, 303–313.
4 M. Che and D. Grignon, in Prostate Cancer: New Horizons in
Research and Treatment, ed. M. Cher, A. Raz and K. Honn,
Springer, US, 2002, vol. 81, pp. 3–17.
5 A. M. DeMarzo, W. G. Nelson, W. B. Isaacs and J. I. Epstein,
Lancet, 2003, 361, 955–964.

Analyst, 2015, 140, 1090–1098 | 1097

151
View Article Online

Published on 09 December 2014. Downloaded by Purdue University on 18/03/2015 15:43:14.

Paper

6 Z. Takats, J. M. Wiseman, B. Gologan and R. G. Cooks,
Science, 2004, 306, 471–473.
7 K. S. Kerian, A. K. Jarmusch and R. G. Cooks, Analyst, 2014,
139, 2714–2720.
8 J. Laskin, B. S. Heath, P. J. Roach, L. Cazares and
O. J. Semmes, Anal. Chem., 2011, 84, 141–148.
9 K. Hiraoka, K. Nishidate, K. Mori, D. Asakawa and
S. Suzuki, Rapid Commun. Mass Spectrom., 2007, 21, 3139–
3144.
10 P. Nemes and A. Vertes, Anal. Chem., 2007, 79, 8098–
8106.
11 L. S. Eberlin, R. J. Tibshirani, J. Zhang, T. A. Longacre,
G. J. Berry, D. B. Bingham, J. A. Norton, R. N. Zare and
G. A. Poultsides, Proc. Natl. Acad. Sci. U. S. A., 2014, 111,
2436–2441.
12 L. S. Eberlin, I. Norton, A. L. Dill, A. J. Golby, K. L. Ligon,
S. Santagata, R. G. Cooks and N. Y. R. Agar, Cancer Res.,
2012, 72, 645–654.
13 L. S. Eberlin, I. Norton, D. Orringer, I. F. Dunn, X. Liu,
J. L. Ide, A. K. Jarmusch, K. L. Ligon, F. A. Jolesz,
A. J. Golby, S. Santagata, N. Y. R. Agar and R. G. Cooks,
Proc. Natl. Acad. Sci. U. S. A., 2013, 110, 1611–1616.
14 X. Zang, C. M. Jones, T. Q. Long, M. E. Monge, M. Zhou,
L. D. Walker, R. Mezencev, A. Gray, J. F. McDonald and
F. M. Fernandez, J. Proteome Res., 2014, 13, 3444–3454.
15 K. Schwamborn and R. M. Caprioli, Nat. Rev. Cancer, 2010,
10, 639–646.
16 E. H. Seeley and R. M. Caprioli, Proc. Natl. Acad.
Sci. U. S. A., 2008, 105, 18126–18131.
17 A. K. Badu-Tawiah, L. S. Eberlin, Z. Ouyang and
R. G. Cooks, Annu. Rev. Phys. Chem., 2013, 64, 481–505.
18 J. M. Wiseman, S. M. Puolitaival, Z. Takáts, R. G. Cooks
and R. M. Caprioli, Angew. Chem., Int. Ed., 2005, 117, 7256–
7259.
19 A. Dill, L. Eberlin, C. Zheng, A. Costa, D. Ifa, L. Cheng,
T. Masterson, M. Koch, O. Vitek and R. G. Cooks, Anal.
Bioanal. Chem., 2010, 398, 2969–2978.
20 A. L. Dill, L. S. Eberlin, A. B. Costa, C. Zheng, D. R. Ifa,
L. Cheng, T. A. Masterson, M. O. Koch, O. Vitek and
R. G. Cooks, Chem. – Eur. J., 2011, 17, 2897–2902.

1098 | Analyst, 2015, 140, 1090–1098

Analyst

21 T. Masterson, A. Dill, L. Eberlin, M. Mattarozzi, L. Cheng,
S. W. Beck, F. Bianchi and R. G. Cooks, J. Am. Soc. Mass
Spectrom., 2011, 22, 1326–1333.
22 S. Santagata, L. S. Eberlin, I. Norton, D. Calligaris,
D. R. Feldman, J. L. Ide, X. Liu, J. S. Wiley, M. L. Vestal,
S. H. Ramkissoon, D. A. Orringer, K. K. Gill, I. F. Dunn,
D. Dias-Santagata, K. L. Ligon, F. A. Jolesz, A. J. Golby,
R. G. Cooks and N. Y. R. Agar, Proc. Natl. Acad. Sci. U. S. A.,
2014, 111, 11121–11126.
23 L. S. Eberlin, A. L. Dill, A. J. Golby, K. L. Ligon,
J. M. Wiseman, R. G. Cooks and N. Y. R. Agar, Angew.
Chem., Int. Ed., 2010, 122, 6089–6092.
24 J. Balog, L. Sasi-Szabó, J. Kinross, M. R. Lewis,
L. J. Muirhead, K. Veselkov, R. Mirnezami, B. Dezső,
L. Damjanovich, A. Darzi, J. K. Nicholson and Z. Takáts,
Science Translational Medicine, 2013, 5, 194ra193.
25 V. Pirro, L. S. Eberlin, P. Oliveri and R. G. Cooks, Analyst,
2012, 137, 2374–2380.
26 M. Cully, H. You, A. J. Levine and T. W. Mak, Nat. Rev.
Cancer, 2006, 6, 184–192.
27 N. Gao, Z. Zhang, B. H. Jiang and X. Shi, Biochem. Biophys.
Res. Commun., 2003, 310, 1124–1132.
28 J. V. Swinnen, H. Heemers, T. van de Sande, E. de Schrijver,
K. Brusselmans, W. Heyns and G. Verhoeven, J. Steroid
Biochem. Mol. Biol., 2004, 92, 273–279.
29 K. K. Wong, J. A. Engelman and L. C. Cantley, Curr. Opin.
Genet. Dev., 2010, 20, 87–90.
30 M. Forina, P. Oliveri and M. Casale, Chemometr Intell Lab,
2010, 102, 110–122.
31 R. Bro and A. K. Smilde, Anal. Methods, 2014, 6, 2812–2831.
32 P. Oliveri, M. C. Casolino and M. Forina, Advances in food
and nutrition research, 2010, 61, 57–117.
33 T. Fearn, NIR News, 2009, 20, 15–16.
34 T. G. Doeswijk, J. A. Hageman, J. A. Westerhuis, Y. Tikunov,
A. Bovy and F. A. van Eeuwijk, Chemometr Intell Lab, 2011,
107, 371–376.
35 M. F. Devaux, P. Robert, A. Qannari, M. Safar and
E. Vigneau, Appl. Spectrosc., 1993, 47, 1024–1029.
36 P. Oliveri and G. Downey, TrAC, Trends Anal. Chem., 2012,
35, 74–86.

This journal is © The Royal Society of Chemistry 2015

